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    Abstract 
Recovery from first episode psychosis (FEP) is heterogeneous and level of cognitive 
impairment at illness onset may explain later recovery (symptom severity and 
functional disability).  Poor ability to self-reflect (a meta-cognitive impairment) and 
over-confidence in judgement (a reasoning bias) are associated with greater symptom 
severity in FEP. However, the relationship between these higher-order cognitive 
constructs and recovery over time is unclear.  It was hypothesised that good Cognitive 
Insight (high self-reflectiveness and low self-certainty) would predict better medium-
term recovery (five years) after the onset of psychotic illness.  An additional interest 
was whether Cognitive Insight would predict recovery status after accounting for 
other cognitive variables (Jumping to Conclusions: JTC bias and IQ).  FEP 
participants (n= 111) completed the Beck Cognitive Insight Scale (BCIS) at illness 
onset, and associations between BCIS scores and symptom and functional recovery 12 
months and five years later, were assessed.  Cognitive Insight did not predict recovery 
in this study.  Rather, only aspects of the BCIS scale that indexed meta-cognition 
(self-reflection items) predicted symptom recovery at five years, whereas reasoning 
processes (self-certainty items) were not associated with symptom recovery.  No 
aspect of cognition in this study predicted functional disability.  Significant 
correlations between the JTC bias, self-certainty and IQ were found, which suggests a 
neuropsychological basis to reasoning processes, separate to meta-cognitive ability.  
Psychological interventions should focus on increasing self-reflective capacity rather 
than correcting reasoning bias to reduce symptom severity in psychosis.   
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INTRODUCTION 
Overview 
This chapter provides the theoretical and empirical framework for the research 
project.  Following a brief explanation of psychosis, the rationale for studying 
recovery in psychosis from the first episode (FEP) and examining different aspects of 
recovery (symptom severity and general function) is provided.  It is suggested that 
cognition at the onset of psychosis can predict both symptom and functional recovery.  
The cognitive constructs under investigation in this study are classified under two 
levels of processing: lower-order cognition, which is examined through the construct 
of general intelligence (IQ), and higher-order cognition: including meta-cognition and 
reasoning processes.  The cumulative effect of two aspects of higher-order thinking 
(high self-reflection and low self-certainty) is thought to represent ‘Cognitive Insight’ 
(Beck & Warman, 2004).  Cognitive Insight has never before been compared to other 
psychosis-relevant cognitive constructs such as the 'jumping to conclusions' (JTC) 
bias or IQ, as potential predictors of recovery in FEP.  This research project has been 
designed to explore these relationships.  To provide a context to this piece of research, 
the sections of this chapter are as follows: a) psychosis and illness course; b) 
cognition in psychosis; c) rationale for current study.   
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Psychosis and Illness Course   
Classifications 
Psychosis can be conceptualised as a family of illnesses characterised by an 
observable loss of contact with reality, which manifests in core symptoms including 
hallucinations, delusions and disorganised speech (DSM-V, American Psychiatric 
Association, 2013).  In the current version of the International Classification of 
Diseases a number of diagnoses are grouped together as psychoses, including 
schizophrenia, schizotypal disorder, persistent delusional disorders, acute and 
transient psychotic disorders, induced delusional disorder, schizo-affective disorders, 
other non-organic psychotic disorders and unspecified non-organic psychosis (ICD-
10, World Health Organization [WHO] 1992).  Schizophrenia, which is the most 
commonly diagnosed of the psychoses (Kirkbride, et al., 2006) is also the most 
frequently researched diagnosis of psychosis (Hegarty, Baldessarini, Tohen, 
Waternaux, & Oepen, 1994; McGlashan, 1988).  Toward the end of the last century, 
researchers began classifying psychosis in terms of symptom syndromes, to suggest 
that not all psychoses experiences reflect one disease process.  One important 
symptom distinction made by Crow (1980) and Andreasen and Olsen (1982) is 
between positive symptoms, which respond well to neuroleptic treatment (defined by 
a presence of aberrant behaviour i.e. delusions and hallucinations) and negative 
symptoms which are less responsive to neuroleptic treatment (defined by an absence 
of usual behaviour i.e. affective flattening, lack of movement, poverty of speech). 
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The notion that psychosis comprises of distinct, but correlated symptom 
dimensions that manifest differently in individual cases, is widely acknowledged 
(Andreasen, Arndt Alliger, Miller & Flaum, 1995: McGorry, 1995; Peralta, Cuesta & 
Farre, 1997; Verdoux & van Os, 2002).  Confirmatory factor analysis supports the 
presence of positive, negative and mood dimensions (manic or depressive) across the 
entire psychosis spectrum (McGorry, Bell, Dudgeon & Jackson, 1998; van Os, et al., 
1999) and also across the general population (Stefanis, et al., 2002).  Proponents of 
the dimensional approach to psychosis suggest it is symptom frequency, severity, and 
associated distress (rather than presence or absence of these symptoms) that 
differentiates diagnoses and prognoses in psychosis (van Os, et al., 1996; van Os, 
Linscott., Myin-Germeys, Delespaul & Krabbendam, 2009).  As such, a dimensional 
classification of psychosis legitimises cohort research that samples across diagnoses 
to study symptom recovery (van Os, et al., 1996).   
 Incidence and prevalence  
The onset of psychotic illness occurs between childhood and middle ages, with 
peak rates in early adulthood (Kessler, Amminger Aguilar-Gaxiola, Alonso, Lee, & 
Ustun, 2007).  Estimates of incidence and prevalence of psychosis tend to vary 
between demographic groups and geography, though it is generally accepted that the 
median prevalence of all clinically significant psychotic experience in the general 
population is around 5% (van Os, et al., 2009).  Lifetime prevalence rates of 
schizophrenia have been reported between 0.4% (Saha, Chant, Welham & McGrath, 
2005) and 0.9% (Perälä et al., 2007) and up to 3.48% for all psychotic disorders 
(Perälä et al., 2007).  The incidence rate of psychosis in the UK for people over 16 is 
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estimated at between 30 to 50 cases per 100,000 people per year (Cheng et al., 2011; 
Kirbride, Stubbins & Jones 2012). 
 
Causes and maintaining factors 
No unitary cause of psychosis has been established to understand the 
psychosis experience, and a bio-psycho-social explanatory model is generally 
accepted (Engel, 1977).  This model suggests that an interaction of many factors, of 
different natures, will contribute to the individual experience of symptoms and level 
of disability in psychosis.  Somewhat akin to a fever, there are multiple pathways to 
and from the psychotic experience and understanding what factors contribute to 
different recovery pathways is the pursuit of modern explanatory models (Bürgy 
2008; Van Os, et al., 1996).   
 Advances in biological psychiatry research towards the end of the last century 
revealed much about the genetic and biological underpinning of psychosis (van der 
Gaag, 2006).  It also positioned psychosis in a nosological dichotomy with 
explanatory models for neurotic disorders (which tend to emphasise the role of stress 
and life events) (Bürgy, 2008).  In recent years however, researchers have begun to 
investigate the role of intra-psychic factors in the development and maintenance of 
psychotic disorder.  This has led many to contest the distinction between psychotic 
symptoms and symptoms experienced in other emotional disorders (Freeman & 
Garety, 2003; Johns & Van Os 2001; Morrison, French & Wells, 2007).  While 
medication remains the first line of treatment for psychosis (NICE guidelines, 2014) 
other treatments are emerging to reflect the psychological aspects of the psychosis 
experience.  For instance, national guidelines in the UK now recommend 16 sessions 
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of individualised cognitive behavioural therapy for the treatment of psychotic 
symptoms (CBTp).  This therapy is an adaptation of CBT for emotional disorders, and 
draws on cognitive models of psychosis to target specific thought processes 
hypothesised to maintain positive symptoms (Jolley, et al., 2015).  These guidelines 
have been recently updated to recommend that CBTp be offered at the earliest 
indication of psychotic symptoms, and at symptom relapse (NICE guidelines, 2014).   
 Prognosis 
 The illness course literature tends to portray a pessimistic view of prognosis in 
psychosis (Zipursky, Reily & Murray 2012).  Psychosis was originally conceived as a 
'premature dementia' which informed expectations that psychotic illness has a 
deteriorating illness course either with, or without partial intermittent remission 
(Kraeplin, 1919).  Indeed many large scale longitudinal studies have suggested that it 
is usual for people with psychosis to endure multiple episodes of illness with 
increasing impairment (Huber, Naber & Lambert 2008; Shepherd, Watt, Faloon & 
Smeeton, 1989; Wiersma, Nienhuis, Slooff & Giel, 1998).  Meta-analysis of 20th 
century research in psychosis suggests that the majority of patients with psychosis 
will not experience substantial improvement during the first six years of illness; 
however authors of this review concede that recovery rates in cohort studies are as 
much informed by diagnostic and recovery conceptualisations, as they are by illness 
related processes (Hegarty, et al., 1994).  For instance, illness course literature in 
psychosis has traditionally been built upon findings from ‘schizophrenia only’ or 
chronically unwell patient samples, wherein poor prognosis and enduring symptoms 
are imbedded into study inclusion criteria (American Psychiatric Association 1994; 
Lieberman, et al, 2008).  In contrast, studies investigating psychosis-spectrum 
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disorders portray a more optimistic illness trajectory (Bromet, Naz, Fochtmann, 
Carlson, & Tanenberg-Karant, 2005; Menezes, Arenovich & Zipursky, 2006) and 
schizoaffective patients have higher rates of symptom remission than those diagnosed 
with schizophrenia, five years after illness onset (Robinson, Woerner, McMeniman, 
Mendelowitz & Bilder, 2004).  Given diagnostic differences, examining illness course 
across different diagnostic groups may provide a clearer indication of recovery rates 
from psychosis, and allow the investigation of common prognostic risk factors across 
the psychosis spectrum. 
The illness course literature in psychosis has also been subject to other 
systematic bias, such as a failure to address the issue of missing data, which results in 
recovery outcomes of the very unwell or very well remaining unknown.  Further, 
studies that follow the course of psychosis over time often recruit participants from 
restricted settings or treatment providers (i.e.inpatient only, or one local service 
provider) (Riecher-Rössler & Rössler, 1998).  Another criticism levelled at studies 
that report on prognosis is that they do not account for multiple dimensions of 
recovery, and do not measure outcomes in a systematic, objective fashion (Hegarty et 
al., 1994; Riechler-Rössler & Rössler, 1998).  The reasons why it is important to 
account for multiple aspects of recovery will be outlined in the next section.   
 How is recovery measured? 
  Recovery has traditionally been defined in psychosis by response to 
pharmacological treatment (Kane, Honigfeld, Singer & Meltzer, 1988).  However, as 
understandings of psychosis have broadened beyond a biological model, so too has 
the impetus to measure multiple types of recovery (Menezes, et al., 2006; Mueser, et 
al., 2002).  Review of the illness course literature in psychosis suggests great 
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variability in the terminology and definitions used to measure recovery (Andreasen, et 
al., 2005; Liberman, Kopelowicz, Ventura & Gutkind, 2002).  However more 
recently, global and standardised clinical rating scales have been implemented to 
calculate a rate of recovery across time, and across studies (Menezes, et al., 2006).  
For example, the Brief Psychiatric Rating Scale (BPRS: Overall & Gorham, 1962) 
and Global Assessment of Function (GAF: Endicott, Spitzer, Fleiss & Cohen 1976) 
are commonly used instruments to evaluate recovery rates in psychosis.  Alongside a 
shift towards standardised measurement of recovery, attention is also increasingly 
paid to the study of non-symptom focused definitions of recovery (level of 
disablement in occupational and social roles suffered in psychosis populations) and 
other person-centred outcomes such as quality of life and social inclusion (Lieberman, 
et al., 2008; Liberman & Kopelowicz, 2005; Slade & Hayward, 2007). 
 Psychopathology and functional disability domains of recovery are frequently 
shown to have separate course trajectories in psychosis (Liberman & Kopelowicz, 
2005; Liberman, et al., 2002).  For instance, symptom trajectories stabilise early after 
the onset of illness, with 75-90% of individuals experiencing remission from positive 
symptoms after 12 months of treatment (Addington, Leriger & Addington, 2003; 
Lieberman, et al., 1993).  However, symptom course is likely to fluctuate, and it has 
been estimated that 90% of individuals diagnosed with schizophrenia or schizo-
affective disorder will experience symptom relapse within five years of illness onset 
(Robinson, et al., 1999).  On the other hand, a poor level of socio-vocational function  
is liable to endure long after the cessation of symptoms, and this pattern of differential 
recovery across symptom vs. function has been identified across the psychosis-
spectrum (Conus, et al., 2006; Robinson, et al., 2004; San, Cuidad, Alvarez, Bobes, & 
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Gilaberte 2007; Singh, et al., 2000; Tohen et al., 2000).  For example, in a sample of 
patients with major-affective disorder with psychotic features, Tohen et al, (2000) 
reported that 63.1% of patients who were symptom free had not managed to return to 
pre-morbid living and working arrangements.  The particular functional difficulties 
faced by patients after recovering from the acute phase of psychosis, include 
struggling to obtain financial independence (Ho, Nopoulos, Flaum, Arndt, & 
Andreasen, 1998; Stirling, et al., 2003), maintain intimate relationships (Salokangas& 
Stengård, 1990) and friendships (Bertelsen, et al., 2009; Harvey, Jeffreys, Mcaught, 
Blizard & King, 2007).  A discrepancy between symptom and functional recovery has 
been found cross culturally (Barnes, et al., 2008; Yamazawa, et al., 2008) and has 
been shown to endure over time (Robinson, et al., 2004).  While functional aspects of 
recovery are thought to take a longer time than symptoms to improve, the level of 
functional disability in psychosis is expected to plateau by 5 to 10 years post illness 
onset and (unlike symptoms) remain relatively stable thereafter (McGlashan, 1988).  
This distinction between the trajectories of symptom and functional outcomes, 
suggests that the predictors of these recovery types, may also differ.  Due to the 
instability of function in the early phase of illness, certain prognostic indicators of 
functional disability may only come to fruition many years after illness onset. 
Tracking predictors of different outcome domains across multiple time-points will 
clarify whether predictors of illness shift as a consequence of illness duration, and 
whether predictors differ across recovery type. 
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 Why track recovery from the first-episode? 
It has been suggested in this thesis that the illness course literature portrays an 
unrepresentative and pessimistic view of prognosis in psychosis (see prognosis 
section).  A more epidemiological approach to studying the experience of psychosis is 
to sample across diagnoses, and also to study psychosis from illness onset.  For 
instance, some patients will never become ill again after experiencing one episode of 
psychosis and these incidences (and associated protective factors) are often neglected 
in psychosis research (Riechler-Rössler & Rössler, 1998).  In contrast to reports of 
prognosis in established psychosis (See prognosis section: Hegarty, et al., 1994) a 
systematic review of 4,100 individuals with First Episode Psychosis (FEP) reported 
good overall recovery outcomes for 42% of this population (i.e. decreased number of 
hospitalisations, decreased symptom severity, higher rates of employment and more 
social inclusion), an intermediate outcome for 35%, and a poor outcome for only 27% 
of participants (Menezes, et al., 2006).     
The study of FEP samples has helped to identify early indicators of prognosis 
(Van Os, et al., 1996).  For instance Australian researchers propose a ‘clinical stage’ 
model of psychosis, which frames FEP as a critical phase in psychosis that can 
determine whether an individual will have milder clinical outcomes or suffer chronic 
illness progression (McGorry, Nelson, Goldstone & Yung, 2010).  In agreement with 
what is known about symptom and functional recovery variability over time, a key 
feature of this clinical model is that prognostic indicators shift with illness 
progression.  This is true of treatment options too, such that those interventions that 
are effective at illness onset may not be effective if initiated once illness progresses.  
Therapeutic input in the early stages of psychosis is thought to change illness 
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trajectories substantially (Birchwood, McGorry & Jackson 1997; McGorry, 1995) and 
many successful interventions have been designed on the basis of this model (Jackson 
& McGorry, 2010; McGorry, Yung, Bechdolf & Amminger, 2008).   
Another advantage of conducting research with FEP samples is that one can 
examine illness onset characteristics before the secondary effects of psychosis (i.e.  
impact of disease, treatments or social consequences of having a serious mental 
illness) confound these variables interest (Lieberman, 1999; Riechler-Rössler & 
Rössler, 1998).  To understand prognostic heterogeneity from psychosis, a challenge 
for research is to unpick which FEP variables predict outcome, when in the recovery 
pathway they become good prognostic indicators, and to identify what aspects of 
recovery they predict.     
Predictors of recovery 
In the following section, well-studied candidate FEP predictors of recovery are 
described. It is argued in this section that recognising the cumulative impact of these 
illness onset characteristics enables a more precise prognosis.   
 Symptom profile at onset 
In line with a trend to study a dimensional classification of psychosis (see 
classifications section) a focus on the cross sectional examination of symptoms and 
associated recovery outcomes has emerged (Bleuler, 1950; van Os et al., 1996).  
Overwhelming evidence suggests that a dominance of negative symptoms at illness 
onset accounts for poorer clinical and functional recovery across the psychosis-
spectrum (Bertelsen et al., 2009; Bodnar Malla, Joober, & Lepage, 2008; Huber, et al, 
2008) and within schizophrenia-spectrum FEP samples (Milev, Ho, Arndt & 
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Andreasen, 2005; Lieberman, et al., 2001; Ram, Bromet, Eaton, Pato & Schwartz, 
1992).  In contrast, acute positive symptoms at illness onset, have been found either to 
have no impact upon recovery outcomes (Malla, Norman, Mancanda & Townsend, 
2002a), or even predict better symptom and functional recovery outcomes (Jablensky, 
et al., 1992; McGlashan, et al.,1988).    
 Demographic Factors 
Demographic factors are commonly cited as predictors of recovery from FEP 
(Menezes et al., 2006).  For example, being female is found to predict better recovery 
(fewer hospitalisations, less severe symptoms and better vocational function) across 
the psychosis-spectrum (Häfner, Maurer, Löffler & Riecher-Rössler, 1991; Jablensky, 
et al., 1992; Robinson, et al., 2004; Salokangas & Stengard 1990; Shepherd, et al., 
1989).  Inconsistent findings have been reported about age at onset of psychosis and 
recovery patterns, with some studies showing an association between earlier illness 
onset and worse recovery outcomes (Harrison et al., 2001; Malla et al., 2002b; 
Rabinowitz, Levine, & Häfner, 2006) although other similarly varied studies, showed 
no such associations (Garety, et al., 1997; Wiersma et al., 2000).  The role of ethnicity 
in psychosis is complex and some conflicting relationships have been reported 
between ethnicity and recovery outcomes (Bhugra, et al., 1997; McKenzie, et al., 
2001).  For instance, one UK based long term follow-up study (18 years) found that 
Afro-Caribbean patients had significantly fewer negative symptoms than their white 
counterparts, though significantly greater use of mental health services (Takei, 
Persaud, Woodfruff, Brockington & Murray, 1998).   
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 Predictor Models of Recovery 
 Given the complexity of psychoses presentations, it is unlikely that ‘good’ or 
‘poor’ recovery outcome can be predicted based upon single predictor variables.  
Rather, different combinations of predictors tend to cluster together, to explain 
variability in recovery rates (McGlashan, 1988).  Illness profiles at FEP are also 
influenced by factors present before the first symptoms of psychosis arise, and it has 
been put forth that psychosis onset is in one sense the end of a cumulative risk 
pathway (Dutta, et al., 2007; Stilo, et al., 2013).  For instance, female gender and 
fewer symptoms at illness onset associate well with pre-onset predictors, such as 
shorter ‘duration of untreated psychosis’ (DUP) (Penttilä, Jääskeläinen, Hirvonen 
Isohanni & Miettunen, 2014; Malla, et al., 2002b, Wiersma, et al., 2000) and better 
pre-morbid functioning (Carlsson, Nyman, Ganse, & Cullberg 2006; Kay & 
Lindenmayer, 1987; Simonsen, et al., 2007).  Conversely, individuals who suffer 
insidious, negative symptom profiles at illness onset are more likely to be male, have 
poor pre-morbid functioning and have experienced a longer DUP (Malla et al., 2002b; 
Malla & Payne, 2005).  Examining relationships between illness onset variables 
within cumulative prognostic models (i.e. comparing these variables’ contribution to 
recovery outcomes) will elucidate whether an underlying disease process is 
responsible for driving the convergence of these variables, or whether these predictor 
variables are simply  independent predictors of better life outcomes more generally 
(Riechler-Rössler & Rössler, 1998).   
Impaired cognition has been forwarded as a disease-specific candidate, which 
underlies the relationship between illness-onset profiles and heterogeneous recovery 
outcomes in psychosis (Frith, 1992; Andreasen et al., 2005).  An advantage of 
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studying the role of cognition as a predictor of recovery is that unlike many other 
predictors of outcome, cognition represents a potentially modifiable factor (Bromet, et 
al., 2005; Insel, 2010) and could be targeted post illness onset to improve prognosis.  
The relationship between cognition and different types of recovery outcomes in 
psychosis (symptom and general function) will be the focus of the next section of this 
chapter. 
 Cognition in Psychosis  
Figure 1 displays the taxonomy of commonly researched cognitive constructs 
in psychosis.  These constructs represent different levels of cognition (lower-order and 
higher-order).  This conceptualisation is borrowed from a psychological learning and 
development model (Bloom, Engelhart, Furst, Hill & Krathwohl, 1956).  According to 
this taxonomy, lower-order cognitive functions represent more basic and 
developmentally primordial cognitive functions, upon which higher-order cognitive 
functions are dependent (Evans, 2008).  This conceptualisation of cognitive function 
assumes a hierarchical structure to the nervous system, such that lower-order 
functions must be intact before higher-order functions can be exercised (Larner, 
2013). However, it is important to highlight that not all information processes in the 
brain can be mapped onto this dual level model, nor are cognitive constructs of this 
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nature entirely functionally distinct1 (Evans, 2008).  Nonetheless, this dual levelled 
conceptualisation felt appropriate and valuable to use in this thesis because it provides 
a neurobiological context, from which to make sense of the cognitive constructs 
compared in this thesis. 
 
                                                 
 
 
 
 
1 There a lack of uniformity in the application of terms in cognitive research.  For instance ‘higher-
order ‘is a term sometimes used to denote  more complex functions carried out by lower-order domains 
such as language and visual-spatial perception (See Schoenberg & Scott, 2011), but this definitions is 
not used in this study. 
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Figure 1: Cognitive constructs relevant to psychosis. 
 
N.B. The cognitive domains and constructs of particular interest to this study are highlighted in yellow. 
Reasoning 
Style 
Meta-
cognition 
Executive 
Function 
Confidence in 
Judgement 
Attributional 
Style 
Self-
reflection 
Clinical 
Insight 
Theory of 
Mind 
Higher-order cognitive domains 
24 
 
Cognitive constructs that can be classified as lower-order functions include 
memory, attention, language, spatial ability, motor skills and processing speed 
(Mirsky, 1969; Seidman, 1983; Gold & Harvey 1993).  Higher-order mental 
phenomena can be understood in neurological terms as functions of the frontal lobes 
of the brain (Scott & Schoenberg, 2011; Shallice & Burgess, 1991) and are considered 
neurologically separate from lower-order cognitive variables (Strauss, Sherman & 
Spreen, 2006).  In traditional neuropsychological assessment, higher-order cognitive 
constructs are considered ‘executive functions’ such as organisation, problem solving, 
sequencing and set-shifting (Evan, 2003).  However, not all aspects of higher order 
thinking are well captured by traditional executive function tasks (Scott & 
Schoenberg, 2011).  These other aspects of higher-order thinking include meta-
cognition (the ability to think about thinking) and reasoning processes (the process of 
making sense of an experience).  It is often these latter aspects of cognition that are 
the focus of change in psychological talking therapies (Moritz, et al., 2014) although 
the extent to which these aspects of cognition are discrete and modifiable is still 
unclear (Garety, et al., 2014).  Cognitive theorists in psychosis accept that both lower-
order and higher-order cognitive disturbances are implicated in the maintenance of 
psychosis over time, although which specific cognitive faculties are involved (or how 
to measure these) is contested (Corlett, Frith & Fletcher, 2009; Williamson, 2006). 
 
 An Integrative Cognitive Model  
  One seminal cognitive model explains the possible cognitive mechanisms 
through which positive symptoms of psychosis can be understood (Garety, Kuipers, 
Fowler, Freeman, & Bebbington, 2001).  The model is primarily focused upon higher-
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order cognitive functions; it proposes that impaired meta-cognition underlies the risk 
for an individual to experience an aberrant cognitive event (i.e.  often leading to 
hallucinations) and distorted or biased reasoning processes then influence whether 
such anomalous experiences are maintained over time, by virtue of how they are 
appraised (i.e. which may lead to enduring delusions).  This model also acknowledges 
the role of what this author would understand as a lower-order cognitive disturbance 
in psychosis, namely poor sensory integration of moment to moment experience with 
stored memories (Hemsley, 1987; 1993).  If this model is valid one may expect that 
aspects of cognition implicated in this model (lower-order cognition, meta-cognition 
and reasoning processes) to be impaired across the FEP population.  Variability in the 
degree and nature of cognitive disturbance in FEP may explain heterogeneous 
recovery seen in this population. 
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 Garety and colleagues’ cognitive model is specific to cognitive predictors of 
‘positive psychotic symptoms’ though it is unclear how these constructs relate to 
general psychopathology or indeed functional disability in psychosis.  In the 
following review of the literature, an overview of lower-order and higher-order 
cognitive functions (as implicated in Garety’s cognitive model) and empirical 
evidence linking these functions to psychosis is reported.  Comprehensive literature 
review2 suggests that certain lower and higher-order cognitive variables are more 
relevant to recovery from FEP than others, and only the most FEP relevant constructs 
will be the examined in this thesis.  These constructs include a well-accepted global 
index of lower-order abilities: general intelligence (IQ: Wechsler, 1939), the ability to 
self-reflect (a meta-cognitive construct) and ‘confidence in judgement’ (a reasoning 
process).  The evidence relating these constructs to particular types of psychosis 
recovery (symptom and general function) will be reviewed.
                                                 
 
 
2
 The following terms were entered into Medline and PubMed search databases: psychosis, cognition, 
neuropsychological, meta-cognition, reasoning, higher-order function, psychological factors, first-
episode, thinking style.  Limits were set so that only English language studies using new empirical data 
published was accessed.  No limits were set on publication dates.  These terms were searched in 
different combinations, e.g.) ((First episode psychosis AND meta-cognition-and symptoms) OR (first 
episode psychoses and neuropsychology and function)) papers were identified from their abstracts as 
relevant and a further relevant studies were identified through a citation search and cross referencing. 
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Lower-order Cognition 
Lower-order cognition is defined as those cognitive functions that are different 
from cognitive functions of the frontal lobe (described here as higher-order cognition), 
and in comparison, represent less complex and earlier developed cognitive functions 
including memory, attention, language, sensory perception and processing speed 
(Mirsky, 1969; Seidman, 1983; Gold & Harvey 1993).  Meta-analysis suggests that 
deficits in lower-order cognitive domains are commonly observed in schizophrenia 
disorders (Alward, Walker & Bettes 1984; Heinrichs & Zakzanis, 1998) with a rate of 
impairment reported between one to two standard deviations below control 
comparisons (Henrichs & Zakanis, 1998), even at first episode (Bilder et al., 2000; 
Censits et al., 1997; Rabinowitz, De Smedt, Harvey, & Davidson 2002; Riley et al., 
2000; Saykin, et al., 1994).  Lower-order cognitive impairment is also documented 
across the psychosis spectrum, although generally to a lesser extent (Reichenberg, et 
al., 2009; Seidman et al., 2002; Zanelli, et al., 2010). 
Lower-order impairment is often present in the childhood (Riechenberg, et al., 
2010) and prodrome phase (Fusor-Poli, et al., 2012) of individuals subsequently 
diagnosed with schizophrenia.  Upon transition to first episode these deficits are most 
pronounced (Eastvold, Heaton & Cadenhead 2007) where they become global (i.e. 
deficits found in multiple domains of lower-order function) and remain stable 
(Addington, Saeedi & Addington 2005; Rund, 1998; Russell, Munro, Jones, Hemsley 
& Murray 1997).  A neuro-developmental account of psychosis suggests that 
psychosis illness is the manifestation of a neural injury between conception and early 
adulthood that becomes evident through brain maturation (Murray & Lewis 1987; 
Weinberger 1987) and impaired performance on lower-order neuropsychological tests 
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are purported to support the existence of this neural injury.  However, no definitive 
pathological indicators in the brain have been found to support the exact nature of 
cognitive disturbance in psychosis (van der Gaag, 2006; Williamson, 2006).  Indeed, 
not all individuals with psychosis show lower-order cognitive deficits (Palmer, et al., 
1997) and variation in cognitive function is especially evident at first-episode (Joyce, 
Hutton, Mutsatsa, & Barnes, 2005).  These findings imply that lower-order cognitive 
deficits reflect only one type of psychosis trajectory (which is perhaps neuro-
developmentally driven), and is plausibly associated with poorer recovery outcomes.  
Using IQ as a measure to index lower-order cognitive deficits is legitimate, as general 
intelligence has been shown to account for a significant proportion of individual 
difference in neurological disturbance across different population groups (Dreary, 
2001). 
IQ and Recovery  
 Poor intellectual function in psychosis is linked at least to some extent, with 
greater symptom severity, particularly negative symptoms (Breier, Schreiber, Dyer, & 
Pickar 1991; Moritz., et al., 2000), whereas positive symptoms are consistently found 
to be unrelated to performance on lower-order cognitive tasks (Basso, Nasrallah, 
Olson, & Bornstein, 1998; Keefe, et al., 2006).  There is substantially better evidence 
linking IQ to real world functioning such as employment and social disability (Green, 
1996; Green, Kern, Braff, & Mintz, 2000; Green, Kern, & Heaton, 2004).  Green and 
colleagues found that global intelligence is associated cross-sectionally with 
functional outcome (Green, 1996; Green, et al., 2000) as well as prospectively (Green 
et al., 2004).  However systematic reviews by Green and colleagues have been based 
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mainly on a selection of studies using relapsing or chronically unwell participant 
samples. 
 Associations between IQ and recovery are less evident when examining 
cognition from the first episode, though there is some tentative evidence that IQ can 
predict medium-term (3 to 7 years) and long-term (7 to 13 years) functional outcome 
in FEP (Allott, Liu, Proffitt, & Killackey 2011).  For example, IQ is a better predictor 
of social function and negative symptoms at four years after illness onset, than 
specific neuro-psychological features such as memory, processing speed or executive 
tasks (rule learning and set-shifting) (Leeson, Barnes, Hutton, Ron & Joyce, 2009).  In 
another large FEP sample (n=115), higher IQ was shown to prospectively predict 
better socio-vocational status as rated by a general assessment of function (GAF) 
(Endicott, et al., 1976) when compared to controls matched on education and age 
(Carlsson, et al., 2006).  In this same study, IQ at illness onset was not predictive of 
short-term (12 month) functional outcome, however, IQ became predictive at three 
year follow-up (Carlsson et al., 2006). This finding supports the clinical stage-model 
theory, such that predictors of outcome may shift as illness progresses (McGorry, et 
al., 2010).   
 
Higher-Order Cognition 
Higher-order mental phenomena relevant to psychoses can be understood in 
neurological terms as functions of the frontal lobes of the brain (Scott & Schoenberg, 
2011; Shallice & Burgess, 1991).  Two aspects of higher-order cognition are 
implicated in Garety, et al’s cognitive model (2001): meta-cognition and reasoning 
style. 
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Meta-Cognition  
Meta-cognition can be understood broadly as the ability to 'think about 
thinking' (Flavell, 1979).  Impaired meta-knowledge is multifaceted and has been 
construed in a number of ways, including the investigation of one’s awareness of their 
own psychosis, referred to as ‘clinical insight’ (David, 1990; David, 2004) and 
mentalisation of another person’s experience: ‘theory of mind’ (ToM) (Frith & 
Corcoran, 1996).  Parnas and Handest (2003) suggest that meta-cognition is a key 
process underlying psychosis; however, an under-evaluation of subjective experience 
in modern psychiatry may have stunted the growth of this field in the past, compared 
with the study of neuro-psychologically measured cognition (Andreasen, 1997; Burgy, 
2008; Parnast & Handest, 2003).  However, the psychological research of Christopher 
Frith and colleagues in the 1980s to 1990s suggested an important relationship 
between impaired meta-cognition and psychotic symptoms.  Their experimental 
research found that compromised meta-cognition accounted for a wide selection of 
symptom presentations in psychosis including:  a) disorders of “willed action” (e.g., 
negative and disorganized symptoms); b) disorders of self-monitoring (e.g., delusions 
of alien control and voice-commenting hallucinations or other “passivity” symptoms); 
and c) disorders of monitoring other persons' thoughts and intentions, including 
delusions of reference and persecution (Blakemore, Smith, Steel, Johnstone, & Frith, 
2000; Franck, et al, 2001; Frith, 1992).   An association between clinical insight and 
ToM, with poorer recovery outcomes in psychosis has been found (Fett, et al., 2011; 
Rosen & Garety, 2005; Ventura, Wood, & Hellemann, 2011). However poor clinical 
insight and impaired ToM are often seen in the context of lower-order cognitive 
impairments (Frith & Corcoran, 1996; Garety & Freeman, 1999; Harrington, Seigert 
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& McClure 2005; Keshavan, Rabinowitz, DeSmedt, Harvey & Schooler 2004). Lack 
of clinical insight and poor ToM is also most prevalent in schizophrenia-spectrum 
disorders (Amador, et al., 1994; Bora, Yucel & Pantelis 2009; Brune, 2005; Mintz, 
Dobson & Romney, 2003; Sprong, Schothorst, Vos, Hox & Van Engeland 2007).  
These associations with lower-order cognition and schizophrenia-spectrum diagnoses 
suggest that these constructs are less central to the cognitive aetiology of FEP (which 
is diagnostically and cognitively more varied).   
Another aspect of meta-cognition that is of key interest to this study is the 
ability to assess the correctness of one’s knowledge. A common way to conceptualise 
this construct, is the ability to be accurately introspective, and recognise one’s own 
subjective fallibility (Koren, Seidman, Goldsmith & Harvey, 2006).  The process of 
self-introspection is distinct from other cognitive constructs, which makes it a 
valuable construct to measure in its own right.  Meta-analysis of brain structural 
studies demonstrates a clear distinction in activation patterns for self-reflection vs. 
reflecting upon other people’s thoughts (social cognition/ ToM), or reflecting upon an 
external problem (belief flexibility) or flexible problem solving (i.e. executive 
function measured tasks) (van der Meer, Costafreda, Aleman & David, 2010).  Unlike 
other meta-cognitive concepts (clinical insight and ToM), self-reflection has few 
neural correlates with lower-order cognition (Nair, Palmer, Aleman & David, 2014) 
and has been put forth as an ecologically valid predictor of recovery from psychosis 
(Koren, et al., 2004; Koren, et al., 2006).  For example, take two people with the same 
poor planning ability; the individual that has awareness of their cognitive difficulties 
may not go ahead with their faulty plan, and subsequently may have better outcomes 
than the individual that lacks this ‘meta knowledge’ (Koren, et al., 2006).   
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One tool which purports to index self-reflection is ‘The Beck Cognitive Insight 
Scale’ (BCIS: Beck, Baruch, Balter, Steer & Warman, 2004).  This instrument contains 
two self-report scales, one of which is a 9 item self-reflective scale that requires 
individuals to rate their endorsement of items such as “if somebody points out that my 
beliefs are wrong, I am willing to consider it” or “even though I feel strongly I am 
right, I could be wrong”.  When individuals endorse these items strongly, they are 
exercising two important meta-cognitive functions: the expression of introspection, 
and a willingness to acknowledge fallibility (Beck, et al., 2004).  It has been reported 
that individuals with psychosis endorse fewer self-reflective behaviours (agree less 
with these BCIS items) compared with non-psychotic psychiatric patients (Beck et al., 
2004) and non-psychiatric controls (Warman & Martin, 2006; Wiffen, 2011).    
 
Self-Reflection and Recovery  
Whether the BCIS self-reflective measure is associated with recovery 
outcomes in psychosis is a new and burgeoning area of research (Riggs, Grant, 
Perivoliotis & Beck, 2012).  Some findings suggest that self-reflective capacity is 
particularly relevant to delusional experience.  For instance, in the BCIS scale 
publication study (Beck, et al., 2004), self-reflective capacity was inversely associated 
with delusional severity across different diagnostic groups. In a different 
schizophrenia-spectrum sample (n= 143) greater self-reflection was associated cross-
sectionally with reduced delusional experience (Engh, et al., 2010).  This relationship 
has also been found in a psychosis-spectrum FEP sample (Buchy, Malla, Joober & 
Lepage, 2009).  In contrast, one study compared delusional and non-delusional 
patients to show the opposite of theoretical expectations: those with delusions actually 
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showed higher self-reflective capacity (Warman, Lysaker & Martin, 2007).  However 
Warman and colleagues’ use of a chronic and poorly represented (n=13) non-
delusional comparison group has been criticised (Buchy, et al., 2009) and may explain 
this anomalous finding.  Whether self-reflective capabilities can predict later 
delusional symptoms is unclear as there are very few prospective studies investigating 
the unique role of self-reflection and symptom recovery in psychosis.  In an acute 
inpatient psychosis sample (n=30) self-reflection was not stable across time (30 days) 
and was unrelated to later symptom severity at discharge (Bora, Erkan, Kayahan, & 
Veznedaroglu, 2007). However, in a larger study that used a less acute outpatient 
psychoses sample (n=78) self-reflective capacity (as measured by the BCIS) was 
correlated with fewer delusional symptoms eight months later (Perivoliotis, Grant, 
Peters, Ison, Kuipers, & Beck 2010).   
Studies that have examined associations between self-reflective capacity and 
other types of psychopathology in psychosis have produced mixed findings.  For 
instance, multiple studies have found strong correlations between a high BCIS self-
reflective score and increased depression (Belvederi-Murri, et al., 2015; Colis, Steer 
& Beck, 2006; Ekinci, Ugurlu, Albayrak, Arslan  & Caykoylu, 2012; Warman, et al., 
2007) and reduced negative symptoms (Bora, et al., 2007; Tranulis, Lepage & Malla, 
2008).  The relationship between self-reflection and hallucinations is not clear, and 
requires more research (Bora et al., 2007; Warman, et al., 2007).  The relationship 
between self-reflection and functional recovery has rarely been examined a priori.  
However, in one study based on an established psychosis sample (n=152), individuals 
with greater self-reflection scores on the BCIS were significantly more likely to be 
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living independently than participants with low-self-reflectiveness (Favrod, 
Zimmermann, Raffard, Pomini & Khazaal, 2008).   
In summary, the research to date that has examined the relationship between 
the BCIS self-reflection scale and recovery in psychosis has mainly been cross-
sectional and conducted with established psychosis patients.  What is unclear is 
whether self-reflection is a useful predictor of prospective recovery in an FEP sample.    
 
Reasoning Style: Confidence in Judgement 
Another key feature of Garety’s cognitive model is the implication of 
reasoning processes in symptom maintenance (Garety, et al., 2001).  In psychosis 
research, reasoning biases are described as cognitive distortions rather than cognitive 
deficits, which is similar to conceptualisations used in explanatory models for 
emotional disorders (Beck & Clark, 1997; Clark & Wells, 1995; Beck 2002).  A 
distorted or biased reasoning style is suggested to influence how an individual 
appraises causality (Bentall, Corcoran, Howard, Blackwood, & Kinderman ,2001; 
Morrison, Haddock & Tarrier, 1995) or casts judgement (Garety, Hemsley & Wessley 
1991).  A rigid and closed reasoning style may for example manifest in ‘over-
confidence in judgement’ (Huq, Garety & Hemsley, 1988).  Over-confidence in 
judgement is thought to be particularly relevant to the experience of enduring positive 
psychotic symptoms (delusions and hallucinations) such that it leads to premature and 
irrational explanations for experiences and makes individuals less likely to seek 
support from mental health services (Huq, et al., 1988). ‘Over-confidence in 
judgement’, and has been found to be qualitatively separate from another well studied 
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reasoning bias: an externalising attributional style (Moritz, et al., 2010).  One method 
of measuring ‘confidence in judgement’ is described next. 
 
The ‘Jumping to Conclusions’ Bias 
The ‘Jumping to Conclusions’ or JTC bias, is measured by the behavioural 
response to a probabilistic reasoning paradigm called ‘The Beads Task’ (Huq, et al., 
1988).  In one version of this task, participants are shown two jars that contain 
coloured beads (orange or black).  Each jar contains beads in a different proportion, 
e.g. one jar contains 85 black and 15 orange beads, and the other jar contains the 
reverse proportion.  Participants are informed of and shown the coloured bead 
proportions, before the containers are removed from their view.  Participants are then 
told that each jar (either the jar containing mainly orange beads or the jar containing 
mainly black beads) has the same probability of being chosen by the researcher 
(50:50) and that beads will be extracted from the selected jar and shown to 
participants one at a time.  It is the participant’s task to decide from which of the two 
jars the beads are being taken, whether it is the mainly orange or the mainly black jar.  
They are told that they should only decide when they are certain.  There is a more 
difficult version of the Beads Task also in common use, in which two jars containing 
coloured beads are presented at a 60:40 ratio (Dudley, John, Young, & Over, 1997).   
The general population tend to apply over cautious data gathering (rather than 
logical reasoning) in their completion of the Beads Task (i.e. request to see more 
beads than statistically necessary to be reasonably certain they have selected the 
correct jar) (Phillips & Edwards, 1966).  However, psychosis populations tend not to 
exercise the same conservatism as the general population in their approach to this task, 
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and rather ‘jump to conclusions’ (i.e. select a jar in haste, before they can be 
reasonably certain their judgement is correct).  At what threshold to define a JTC bias 
(i.e. Draws to Decision: DTD) is operationalised differently across studies (Fine, 
Gardner, Craigie, & Gold, 2007).  In previous FEP studies, responding after seeing 
only one or two beads has been used to indicate a JTC bias (Dudley, et al., 2011; 
Falcone, et al., 2014).   
  A dose–response relationship between JTC and liability to psychosis appears 
to operate, such that deluded psychotic individuals show the highest rates of JTC bias, 
although the bias is still found in non-delusional psychosis samples (Bentham, et al., 
1996; Menon, Pomarol, Clotet, McKenna, & McCarthy, 2006; Moritz & Woodward, 
2005) and is found more frequently in populations with a psychosis vulnerability 
(first-degree relatives) than in non-liable control populations (Lincoln, Ziegler, Mehl, 
& Rief, 2010; van Dael, et al., 2006).  In established psychosis the JTC bias has been 
shown to be stable over time (Peters & Garety, 2006; So, et al.,2012) whereas in some 
other samples (including FEP) this bias is not consistently present across time 
(Menon, Mizrahi & Kapur, et al., 2008; Ormrod, et al.,2012; Woodward Munz, 
LeClerc, & Lecomte, 2009).  Approximately 30-60% of people with psychosis 
spectrum disorders do not present with the JTC bias (Garety & Freeman, 1999) and so 
it is reasonable to speculate that this may be an important cognitive marker of 
recovery variance within patient samples.  However, the JTC bias is not entirely 
psychosis-specific, and has also been found in a non-liable control population (i.e. 
healthy volunteers who endorse no psychosis-like thinking and do not have familial 
risk to psychosis) at a rate of 25% (Falcone, 2013).  This suggests that caution is 
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warranted when using the JTC as an independent prognostic measure, given that its 
specificity to psychosis is questionable.   
Some of the inconsistencies in research regarding ‘jumping to conclusions’ and 
its specificity to psychoses may be due to construct validity of the Beads Task. Indeed, 
it is widely recognised that the JTC reasoning style is influenced by both state and 
trait characteristics (Moritz &Woodward, 2005).  Therefore, while the Beads Task 
instructs participants to choose a jar “only once you are certain”, there is no assurance 
that certainty or confidence is driving the behavioural response to this task.  In reality, 
the response to the Beads Task is likely to also be influenced by multiple factors, such 
as need for closure (Colbert & Peters, 2002), personality (Bensi, Giusberti.  Nori, & 
Gambetti, 2010), and state-anxiety levels (Freeman, 2007).  Lower-order cognitive 
capacity is also implicated in response to this task, as many studies have found that a 
tendency to JTC is associated with poorer autobiographical memory (Moritz, 
Vitzthum, Randjbar, Veckenstedt & Woodward, 2010a) impaired working memory 
(Freeman, et al.,2014) and lower IQ (Lincoln, et al., 2010; van Dael et al., 2006).  For 
example, Lincoln and colleagues found that the association of the JTC bias with 
psychotic symptoms was rendered non-significant once IQ was controlled (Lincoln, et 
al., 2010).  In a study of psychosis and depression, Bentall, et al., (2009) found that 
the lower an individual’s IQ score, the hastier the data-gathering style, a finding which 
was recently replicated in an FEP sample (Falcone, et al., 2014).  Indeed some 
researchers refer to the JTC bias as relatively ‘benign’, though they argue that in 
combination with lower-order cognitive impairment, this reasoning style may predict 
prognosis in psychosis (Moritz & Woodward 2007).  Given the lack of clarity over the 
construct validity of the JTC bias, it may be useful to compare this construct with a 
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more direct measure of ‘confidence in judgement’.  Such a measure is described 
below.   
Self-Certainty  
The self-certainty scale of The Beck Cognitive Insight Scale (BCIS, Beck et 
al., 2004) is designed to be administered along with the self-reflective scale already 
discussed (see meta-cognition section).  Much like the JTC bias, the self-certainty 
scale is designed to examine ‘confidence in judgment’ (Beck, et al., 2004) and 
contains six items including “if something feels right, it is right” and “I can trust my 
own judgement at all times”.  In the original publication of the BCIS instrument, the 
mean self-certainty score of inpatients with a psychosis diagnosis was significantly 
higher than the mean self-certainty score of inpatients without a psychosis diagnosis 
(Beck, et al., 2004).  Further, BCIS self-certainty scores are found to be higher in FEP 
(Buchy et al., 2009) than in chronic psychosis samples (Warman et al., 2007; Engh, et 
al., 2010).  One possible explanation for higher self-certainty scores in FEP than 
established psychoses is that confidence in judgement reduces with socialisation to 
medical model of psychosis.  For instance, when someone receives treatment and 
support to understand their delusions, they may be better able to cast doubts on the 
certainty of their judgments (Moritz & Woodward, 2007).  Warman and Martin (2006) 
found that delusion proneness in a student-non clinical population was significantly 
positively correlated with self-certainty, suggesting that, like evidence relating to the 
JTC bias, high scores on this scale may signal vulnerability to psychosis (Colbert & 
Peters; 2002; Lincoln, et al., 2010; van Dael, et al., 2006).  The self-certainty scale has 
not been measured as extensively as the JTC bias, however emerging evidence 
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suggests it shows similar associations with lower-order cognition including memory, 
IQ (Nair, et al., 2014) and executive functions (Cooke, et al., 2010). 
 
Confidence in Judgement and Recovery  
Garety’s cognitive model suggests that reasoning processes, such as 
‘confidence in judgment’ may play a role in maintaining positive symptoms in 
psychosis and this is somewhat supported by empirical evidence relating to the JTC 
and BCIS self-certainty scale.  The JTC bias is widely found to be present alongside 
paranoid delusions and delusional conviction (Fine, et al., 2007; Garety, et al., 2005; 
Langdon, Ward, & Coltheart, 2010; Lincoln, et al., 2010; So, et al., 2012; Woodward, 
Munz, LeClerc & Lecomte, 2009) and is a better predictor of these delusional 
experiences when compared to another reasoning process (attributional style) (Garety 
& Freeman, 1999; Garety & Freeman, 2013).  Evidence linking the JTC bias with 
other psychopathology is less clear.  For example, a recent study of established 
psychosis, found no global symptom differences between patients who did and did not 
jump to conclusions in a cross-sectional design (Freeman, et al., 2014).  However, this 
study used the more difficult version of this task (40:60 ratio), which may have 
increased the likelihood of lower-order cognition confounding the relationship 
between the JTC bias and symptom severity.  Further, the sample examined by 
Freeman and colleagues, presented with a limited range of symptoms (all subjects had 
persistent persecutory delusions) which may also have hampered the detection of true 
correlations.   
The relationship between the JTC bias and symptom severity in FEP samples 
is more inconsistent.  For instance, one FEP study found no cross sectional difference 
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in delusional symptoms, nor was there a difference in severity of hallucinations, 
anxiety, depression or number of hospitalisation, between those who did or did not 
show the extreme JTC bias (Dudley, et al., 2011).  However, a study using a more 
heterogeneous FEP sample, found the JTC bias was correlated with delusional 
symptoms, even after accounting for neuropsychological variables (Falcone, et al., 
2014).  The cross-sectional findings from these two research groups are different 
despite very similar research designs and sample characteristics (i.e. both studies used 
the same DTD thresholds, 15:85 beads ratio version, and the same proportion of 
participants endorsed a JTC response).  However, the negative findings in Dudley and 
colleagues study may be due to the fact that these researchers categorised delusions 
using a binary variable (delusions present or absent) which may have limited their 
power to detect relationships between symptom severity and the JTC bias.  
Interestingly, both of these research groups went on to examine FEP participants 
longitudinally (Dudley, et al, 2013; Falcone, et al, in press) to show that the JTC bias 
became a predictor of the persistence of delusions over time.  An important caveat to 
these prospective FEP findings was that JTC only predicted later symptom recovery in 
a subset of participants (those who showed the JTC bias across baseline and follow-
up).  Such findings provide some support that the JTC bias represents a stable, trait-
like reasoning style in some individuals, and therefore may be useful for predicting 
outcome prospectively.   
When ‘confidence in judgement’ is measured using the BCIS self-certainty 
scale, a relationship with symptom severity is also found in some studies (though the 
literature base for the self-certainty measure is more limited than JTC).  For instance, 
in a sample of older patients with schizophrenia or schizoaffective disorder, the self-
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certainty index correlated significantly, though weakly with total psychopathology 
scores, in a mildly symptomatic sample (Pedrelli, et al., 2004).  In another established 
psychosis sample with more acute symptoms, high self-certainty was significantly 
correlated with positive symptoms of psychosis, though not related to negative 
symptoms (Bora, et al., 2007).  Only two studies have examined the relationship 
between self-certainty and symptom outcomes in FEP, and neither study found these 
variables to be associated cross-sectionally (Buchy, et al., 2009; Tranulis, et al., 2008).  
However, the prospective value of this measure has not been tested in FEP. 
In summary, review of the confidence in judgement literature (as measured by 
the JTC bias and BCIS self-certainty scale) suggests that this concept has some scope 
for predicting the maintenance of positive symptoms of psychosis, particularly 
delusions.  However, its prospective value and relationship with other 
psychopathology outcomes in FEP has only been tentatively evidenced (Dudley, et al., 
2013; Falcone, in press).  There is no literature examining this construct in relation to 
functional outcomes in psychosis.  One particular reason for inconsistencies between 
the JTC and recovery is that studies report different base rates of JTC within samples, 
use different methods of defining the JTC and employ different versions of the Beads 
Task.  It is not clear from the literature whether instruments of reasoning (JTC and 
self-certainty) converge or which measure is better associated to recovery.  Comparing 
these factors could help validate whether these instruments tap into the same 
‘confidence in judgement’ construct that they purport to index. 
Cognitive Insight 
Review of the cognitive literature thus far has highlighted how meta-cognition 
(self-reflection) and reasoning style (confidence in judgement) are relevant constructs 
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in psychosis.  However, this review has also revealed that an understanding of these 
constructs’ relationship to recovery outcomes in FEP, and over time, is limited.  A core 
message of Garety and colleagues’ cognitive model of psychosis is that it is the 
integration of cognitive processes that leads to positive symptoms enduring over time, 
not one single cognitive aspect in isolation (Garety, et al., 2001).  The Beck Cognitive 
Insight Scale (BCIS) (which has so far been discussed in relation to its two 
independent sub-scales) can also assess the cumulative impact of higher-order 
cognition: through a measure which the authors term ‘Cognitive Insight’.  Cognitive 
Insight is derived by deducting the BCIS self-certainty scale item total from the BCIS 
self-reflective scale item total, and Beck and Warman (2004) suggest that high self-
reflectiveness (greater meta-cognition) and low self-certainty (lower confidence in 
judgement) is the formula for good Cognitive Insight.  The rationale underlying this 
combination score is that these scales are considered to be qualitatively distinct, 
though also co-dependent.  The relationship between these constructs are such that a 
high level of self-certainty might diminish one’s ability or willingness to be 
introspective, and likewise good self-reflective skills may enable one to redress 
cognitive bias (Beck & Warman, 2004).  The idea that these constructs operate 
together is supported by neuro-imaging studies, showing that individuals with damage 
to neural areas which are considered responsible for self-reflective capacity (cortical 
midline structures in the pre-frontal lobe) are also over-confident in their cognitive 
capacity and performance (van der Meer, et al., 2010).   
Comparisons of the BCIS composite scores obtained from psychiatric 
inpatients with psychosis vs. psychiatric inpatients without a psychosis diagnosis are 
significantly different with large effect size (with non-psychosis patients showing 
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greater Cognitive Insight).  This difference is of greater magnitude than the difference 
between these groups when scores on BCIS subscales are individually compared 
(Beck, et al., 2004).  The specificity of poor Cognitive Insight to psychosis disorders 
is further supported by studies of the BCIS in control populations.  For instance, 
delusional prone controls do show high self-certainty scores, but also show high self-
reflective capacity (Warman & Martin, 2006).  This suggests that in the general 
population, the capacity to reflect may protect against transition to psychotic disorder.   
It is plausible that Cognitive Insight within psychosis populations may vary and that 
poor Cognitive Insight is a marker of poor prognosis.   
Cognitive Insight and recovery 
Three different studies have found that the correlation between the BCIS 
composite score and symptom outcome is stronger than the correlation between 
recovery and either of the BCIS subscales separately (Bora, et al., 2007; O’Connor et 
al., 2013; Periviolotis, et al., 2010).  For instance, a psychosis-spectrum FEP study 
found that Cognitive Insight at illness onset is a better predictor of overall symptom 
severity at 12 month follow-up, than lower-order cognition, executive function or 
insight into illness (O'Connor, et al., 2013).   
Cognitive Insight may be particularly relevant to understanding recovery 
outcomes in talking therapies.  For example, the BCIS composite score has been 
shown to mediate the response to various treatments including CBTp, cognitive 
remediation and social skills (Burton, Vella, & Twamley, 2011; Granholm, Auslander, 
Gottlieb, McQuaid, & McClure, 2006; Perivoliotis, et al., 2010) such that increases in 
Cognitive Insight was associated with lower positive, negative and general symptom 
severity.  Cognitive Insight also shows prospective value; for instance, in an 
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established psychosis spectrum sample (n=69) better Cognitive Insight prior to 
engaging in a cognitive training intervention, predicted less severe positive symptoms 
and reduced depression 6 months later, in spite of the fact that Cognitive Insight did 
not associate with these factors cross-sectionally (Burton, et al.,2011).  Finally, in a 
community outpatient psychosis sample, the individual BCIS subscales showed 
different relationships with symptom outcome, with higher baseline self-reflective 
scores associated with reduced delusional severity, whereas low self-certainty 
predicted fewer hallucinations.  Importantly however, the combination of these 
subscales (Cognitive Insight) at study entry predicted overall symptom severity post 
CBTp treatment (8 months later) (Perivoliotis, et al., 2010).   
 The relationship between Cognitive Insight and occupational and social 
domains of function is scarcely researched and has been identified as an area in need 
of better understanding (Riggs, et al., 2010).  Good Cognitive Insight has been found 
to predict independent living in psychosis (Favrod, et al., 2008), though is not related 
to quality of life (Carlson, et al., 2009).  In the only FEP prospective follow-up study 
to examine associations between Cognitive Insight and overall functional disability, 
no relationship was found at 12 months (O’Connor, et al., 2013).  However, given that 
the clinical stage-model theory in psychosis suggests that predictors can shift with 
illness progression (Alott, et al., 2011; McGorry, et al., 2010) it may be useful to 
examine these variables relationship at a later stage in the recovery pathway.  To this 
author’s knowledge, the association between Cognitive Insight at illness onset and 
recovery from psychosis in the medium-term (3 to 7 years following FEP) has not 
been examined.    
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Summary of section 
 
The aim of the previous section was to evaluate whether cognitive constructs 
relevant to a cognitive model of psychosis (Garety, et al., 2001) are associated with 
symptom and functional recovery.  IQ, self-reflection and confidence in judgement 
have been found to associate with aspects of recovery in psychosis, some more 
tentatively than others.  Relationships between these cognitive variables and recovery 
appear to operate differently in established psychosis and FEP, which is in agreement 
with stage-model understandings of psychosis (McGorry, et al., 2010).  This review 
has also highlighted nuanced relationships that exist between particular aspects of 
cognition and recovery type (IQ with functional recovery, JTC bias with delusional 
severity).  One critique of the literature is that cognitive variables are often tested 
cross-sectionally and without hypothetical expectations (Cooke, Peters, Kuipers, & 
Kumari, 2005).  This has resulted in some confusing and equivocal findings in the 
field.  Potentially overlapping cognitive constructs need to be compared in the same 
cohort, to verify that they are indeed distinct, and to evaluate their relative 
contribution toward recovery outcomes. 
Rationale for Current Study 
There is a clear clinical rationale for examining cognitive predictors in 
psychosis, as Cognitive Behavioural Therapy for psychosis (CBTp) is endorsed as an 
effective treatment for improving recovery outcomes in psychosis (NICE guidelines, 
2014). However at this stage, it is not clear what cognitive mechanisms are involved 
in symptom change during therapy (Garety, et al., 2014).  It is intuitively plausible 
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that both meta-cognition and reasoning processes are important mechanisms of change 
in CBTp as increased awareness and self-reflection (meta-cognition) may allow 
reasoning biases (such as overconfidence in judgement) to be recognised and 
challenged. Equally plausibly, this relationship may operate in reverse. However, 
given that lower-order cognitive disturbance is known to be prevalent in FEP, it is also 
important to account for this before the unique role of higher-order cognition in 
recovery can be endorsed.   
A research question was therefore proposed: Can Cognitive Insight predict 
recovery from psychosis in a first-episode cohort? The rationale for asking this 
question is provided by a cognitive model of psychosis which hypothesises that 
impairment to higher-order cognitive functions (measured by the BCIS) contributes to 
the formation and maintenance of psychotic illness (Garety, et al., 2001).  Recovery 
was operationalised in this study in terms of psychiatric symptoms, hospital 
admissions and psychological, social and occupational function to enable relationships 
between recovery type to be examined.  This distinction between symptom and 
functional recovery is important because evidence suggests that these recover domains 
operate independently, and may have different prognostic indicators.   
Relationships between specific cognitive factors and recovery will need to be 
examined concurrently to factor out overlapping variance between cognitive factors.  
The BCIS self-certainty scale is considered a more direct indicator of ‘confidence in 
judgement’ than the JTC bias, however given that the latter has been thoroughly 
researched to show established associations with delusional symptoms, it may be 
useful to account for this variable before drawing conclusions about the unique 
contribution of the BCIS scales.  IQ will also be accounted for, given the relevance of 
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lower-order cognition to cognitive models of psychosis, and because there is evidence 
linking IQ to functional recovery in psychosis.  The BCIS instrument will be used to 
measure Cognitive Insight (BCIS composite score) and the two BCIS subscales will 
also be examined in isolation (self-certainty and self-reflection) to assess their relative 
contribution to recovery.  The literature suggests that correlates between cognition and 
outcome in psychosis may change over time (Allott, et al., 2011) and that illness 
trajectories become more stable and discrete over time (McGlashan, 1988).  Indeed 
the evidence presented in this review suggests that some cognitive variables’ 
relationship to outcome may become stronger as illness progresses (Carlsson, et al., 
2006).  The illness course literature generally defines short-term outcomes in 
psychosis ranging from 6 months to 2 years and medium-term outcomes from 3 to 7 
years (Allott et al., 2011; McGlashan, 1988).  Therefore changes to the relationship 
between Cognitive Insight and outcome changes in the short-term (12 months post 
FEP onset) and the medium-term (five years post FEP onset) may be observed.  
Results from this research may provide evidence in relation to cognitive models in 
psychosis, and inform interventions to target cognitive predictors of prognosis in FEP. 
 
 Study Hypotheses 
Based on the available evidence, the primary hypotheses for this study are as follows 
1. Cognitive Insight (as measured by the BCIS composite score) will predict 
medium-term symptom severity in FEP after controlling for the JTC bias.   
2. Cognitive Insight (as measured by the BCIS composite score) will predict 
medium-term functional disability in FEP after controlling for IQ. 
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3. The relationship between Cognitive Insight (as measured by the BCIS 
composite score) and symptom and functional outcome will be stronger in the 
medium-term, compared with the short-term in FEP.
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 METHOD 
Design  
This section will firstly provide an overview of the current study before 
describing the broader context from which this study is derived. 
The current study  
This study used a within subject longitudinal design to analyse relationships 
between independent variables of interest (Cognitive Insight, JTC, IQ) collected at the 
first onset of psychosis (Time 0) and the dependent variables of interest (symptom and 
functional recovery outcome variables) collected at 12 month follow-up (Time 1) and 
five year follow-up (Time 2).  Ethical approval for the study was obtained from the 
Institute of Psychiatry and South London and Maudsley NHS Foundation Trust 
Research Ethics Committee (see appendix A) and the psychology department at Royal 
Holloway University (see appendix B). 
The broader GAP project context 
This study was imbedded within a larger project funded by the National 
Institute of Health Research (NIHR) Biomedical Research Centre.  This larger project 
was the Genetics and Psychosis (GAP) study and was conducted through the 
Psychosis Studies Department at the Institute of Psychiatry, Kings College London.  
The GAP project began in 2006, and recruited individuals between the ages of 18 and 
65 experiencing psychosis for the first time.  The recruitment of participants at Time 0 
ceased in May 2011, and the longitudinal aspect of this study is ongoing.  The GAP 
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project investigates a wide variety of environmental and genetic risk factors of 
psychosis by collecting biological markers, physical health measures, psychological 
and socio-demographic information on both individuals with first episode psychosis 
and non-psychosis controls.  All researchers involved in the larger project were trained 
assistants, psychologists and psychiatrists, and worked under the supervision and 
guidance of senior researchers and principle investigators.  Formal training on all 
individual measures administered in the research battery was provided and 
consistency checks were completed. 
The author’s role in the GAP project 
The author of this thesis actively contributed to, and shared responsibility for 
data collection across the baseline and longitudinal aspects of this study, with a special 
interest and management of neuropsychological data.  The author was not responsible 
for the selection of materials for the larger study, but did design the study that is 
reported in this thesis, selecting measures from the larger study to test current 
hypotheses.  The author also held a main role in facilitating service user-involvement 
in the design and implementation of the GAP project, and managing follow-up 
procedures.  
 
Service-user involvement 
The GAP project received funding from the Biomedical Research Centre 
(BRC) on the specification that stakeholder involvement was promoted through the 
research.  To this end, the BRC service user advisory group were consulted during the 
GAP project to provide opinion on materials used to disseminate research findings 
with participants (i.e. newsletter updates of research findings, and leaflet material for 
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potential participants).  Stakeholder Participation was also encouraged through 
consultation with the Service User Research Enterprise (SURE).  SURE operates 
within the Institute of Psychiatry and employs people who have research skills and 
have also been users of mental health services.  Their research tests the effectiveness 
of mental health services and treatments from the perspective of people with mental 
health problems and their carers.  This author attended regular SURE meetings, to 
seek guidance and collate ideas to facilitate the stakeholder participation within the 
GAP team.  This ongoing consultation with SURE enabled the involvement of service 
users to be closely monitored and evaluated.  This ensured the avoidance of a 
tokenistic approach to service-user involvement in favour of service-user led 
collaboration (Rose, 2003).  Based on this consultation, the author also collaborated 
with two service users (one client and one carer) who contributed to recruitment 
processes in the study.  For instance, one of these service users attended a training 
session with GAP researchers to relay their experience of what it was like to be on an 
acute psychiatric ward for the first time as a patient with psychosis, to encourage 
researchers to engage patients sensitively on the ward.  These service-users also talked 
to participants about study involvement, which was especially useful when potential 
participants had concerns about the study (i.e. some participants had a poor 
relationship with health professionals and felt distrustful of researchers).  Both service 
users recruited to be involved in the GAP research project were CRB checked and 
given honorary contracts thought the Institute of Psychiatry to carry out this direct 
research. 
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Participants  
Participant numbers varied across time-points in this study.  The total number 
of participants in this study was 111 participants at Time 0, 95 participants at Time 1 
and 90 participants at Time 2.  The majority of Time 0 participants were male (62%) 
and the median age was 28 years (sd= 9.1, range 18 -58).  At study entry, 79.8% of 
participants were psychiatric inpatients and 20.2% were recruited from community 
mental health teams (CMHTs) and home-treatment teams (HTTs).  Further descriptive 
information about these participants is provided in the results chapter.  Power 
calculations confirm that the sample size obtained in this study (n=90 to 111) provided 
80% power to detect a medium effect between Cognitive Insight and Time 2 recovery 
outcomes, after accounting for other potential confounders (Clarke-Carter, 2009). 
Inclusion Criteria  
An important epidemiological consideration of this study was that all 
participants were recruited from the catchment area which was served by the South 
London and Maudsley (SLAM) NHS Foundation Trust: Southwark, Lambeth, 
Croydon and Lewisham.  To avoid systematic sampling bias, efforts were made to 
recruit participants from all secondary mental health-care providers in the catchment 
area.  In order to be considered eligible for participation in the GAP study >1 week of 
active DSM IV recognised psychotic symptoms (in the absence of substance 
intoxication) was required (American Psychiatric Association, 1994).  The following 
inclusion criteria were also applied: contact with psychiatric services for psychosis <6 
months; fluent English speaker; aged between 18 and 65 years old; psychosis 
identified as having a non-organic cause ( e.g. differential diagnoses discounted such 
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as medically induced psychosis i.e. delirium, history of head injury or neurological 
condition i.e. Parkinson’s disease or Alzheimer’s disease).  The following exclusion 
criteria were applied: time in contact with psychiatric services for psychosis > 6 
months; poor English fluency (i.e. the participant would require an interpreter); a 
history of previous treatment for the presence of psychosis or a known organic cause 
of psychosis. 
Measures 
Global Assessment of Functioning: GAF (Endicott, Spitzer, Fleiss & Cohen, 1976).   
 The GAF measure is a widely used observer-rated instrument to rate clinical 
and functional status on a scale from 1 to 100.  For the purpose of this study, this 
measure was split into two separate scales to measure psychiatric symptoms (GAF-S) 
and social and occupational function (GAF-F).  This modification to the original scale 
is known to improve the psychometric properties of the measure (Pedersen, Hagtvet & 
Karterud, 2007) (see appendix C).  The scale is divided into 10 equal scoring 
intervals, and descriptions for each interval rating are provided with the measure.  For 
instance ratings below 30 on the GAF symptom scale indicates that behaviour is 
influenced by psychotic symptoms, whereas ratings below 30 on the GAF function 
scale indicates that an individual is not maintaining social roles and may have 
difficulty initiating activities of daily living independently.  Most outpatients will be 
rated 31 to 70, and most inpatients between 1 and 40 (Endicott, et al., 1976).  A 
previous FEP study has used a threshold of >59 on the GAF to define ‘recovery’ in 
FEP (Bertelsen, et al., 2009) and this threshold definition was also adopted for the 
purpose of this study.   
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Authors of the original GAF scale suggest that information needed to rate a 
GAF score may come from “any source, such as direct interview of the patient, a 
reliable informant, or a case record” (Endicott, et al., 1976, pg.767).  This study used 
both face to face interview and clinical records to rate GAF outcomes.  When 
psychiatric records needed to be accessed this was done via an electronic patient 
journey system (ePJS) which is the central recording system for all mental health 
service providers in the South London and Maudsley NHS trust.  The time period for 
GAF ratings is generally for the preceding week, although in special circumstances, 
the scales’ authors permit a longer time period to be used to rate this measure 
(Endicott, et al., 1976).  For the purpose of this study, the GAF ratings represented a 
period of the preceding week, which was extended to one month if appropriate 
information was not available (i.e. the week of interview was not representative of 
previous weeks, or information from clinical records was sparse).   
  The GAF instrument shows good sensitivity to change in symptom severity 
over time when rated by trained researchers (r=0.83, p<0.05) (Endicott, et al.,1976) 
and shows satisfactory inter-rater agreement, ranging from r = .61 to .91 across five 
studies, using a variety of observations including structured interview, vignettes and 
case records (Endicott, et al., 1979).  In the studies on which the original scale inter-
rater agreement was based, the highest intra-class correlations (ICC) was achieved 
through direct interview (ICC=.91) whereas collecting GAF from clinical records was 
less reliable (ICC=.69).  The most inconsistent GAF ratings were derived from 
interview transcripts (ICC=.61).   In this study, meetings were held weekly to discuss 
new participants and rate the GAF scores based on consensus amongst researchers 
after reviewing interview observations and clinical records.  The means of collecting 
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GAF at follow-up varied and were subject to psychometric investigation (inter-rater 
agreement between researchers and a convergent validation of GAF ratings collected 
through different observation methods: interview vs. clinical records).  Findings 
pertaining to these psychometric analyses will be reported in the results chapter. 
Number of inpatient admission days 
The duration of episodes of care that participants had experienced since their 
first contact with services was collected in this study to determine number of 
admission days in psychiatric hospital.  This was identified through examination of 
care episode dates as recorded on the ePJS system.  Total days spent as an inpatient 
was calculated on the same date that the GAF follow-up score was rated.  In order to 
compare hospital admission time across the cohort (where follow-up duration varied) 
number of admission days was divided by length of follow-up time to estimate the 
proportion of follow-up time spent in hospital, averaged over a five year period.   
The Positive and Negative Syndrome Scale: PANSS (Kay, Fiszbein & Opler, 1987)  
The PANSS instrument is widely used in research settings to measure 
psychopathology in psychosis populations (see appendix D).  The instrument is 
divided into three separate scales: a seven-item positive symptoms (PANSS-P: range = 
7 to 49), a seven-item scale to evaluate negative symptoms (PANSS-N: range = 7 to 
49) and a 16 item scale to examine generalised psychopathology including mood, 
social engagement and general presentation (PANSS-G: range = 7 to 112).  Each item 
is scored on a scale of 1 to 7: absent, minimal, mild, moderate, moderate severe, 
severe and extreme.  A score of 4 (moderate) or higher indicates the presence of 
clinical psychopathology.  In this study, the item ratings were completed through 
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interview with participants and by collecting collateral information from health-care 
workers based on seven days prior to assessment.  Each PANSS scale can be analysed 
separately to examine symptom dimensions or the tool can be interpreted as a total 
score (range 30-210) into severity categories: mildly ill (<58), moderately ill (58-74), 
markedly ill (75-95) and severely ill (>96) (Leucht, et al., 2005). 
This scale has been subject to thorough psychometric examination.  
Discriminant and convergent validity is demonstrated by the scales significant 
correlations with a series of clinical, genealogical, psychometric, and historical 
assessments (e.g.  The Brief Psychiatric Rating Scale has a partial correlation with the 
composite PANSS score =.50, p <0.05, Kay, Opler & Lindenmayer, 1988).  In this 
study, each PANSS scale showed adequate internal consistency (Cronbach’s α =.70 
(PANSS-P) α =.76 (PANSS-N) and α =.63 (PANSS-G).  Each item has specific 
criteria for each point on the scale to assist with administration and scoring, and 
researchers were trained to rate the PANSS during study induction using clinical 
vignettes.  PANSS has been shown in previous studies to have high levels of inter-
rater reliability after sufficient training (Kay, et al., 1988; Müller & Wetzel, 1998).  In 
this study, inter-rater agreement coefficients for pairs of raters (n=22) were calculated 
using a Spearman-Brown formula (agreement amongst multiple observers corrected 
for number of observers).  Mean level of agreement researchers on this scale was r= 
0.814, which is above conventionally accepted thresholds for adequate inter-rater 
agreement (Fleiss, Levin & Paik, 1981).   
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Diagnoses 
 
 Diagnoses were made according to DSM-IV criteria (APA, 1994) using the 
Operational Criteria (OPCRIT; McGuffin, Farmer & Harvey, 1991).  OPCRIT allows 
individual symptom scores to be entered into a database, to provide a computerised 
algorithm to output an appropriate diagnosis.  Scores entered were based on the SCAN 
interview (Schedules for Clinical Assessment in Neuropsychiatry, WHO 1994) which 
is a face to face structured assessment, supplemented by observations recorded in the 
clinical notes for the month following the participant’s first contact with psychiatric 
services.  The first month was used in order to increase reliability of diagnoses across 
participants who had been in contact with services for various time periods.  All 
diagnoses were carried out by qualified psychiatrists subject to inter-rater reliability 
checks (ICC= .97).  Diagnoses were grouped into two categories: ‘non-affective 
psychosis’ (ICD-10: F20-F29: schizophrenia, schizophreniform disorder; atypical 
psychosis; psychosis not otherwise specified) and ‘affective psychosis’ which included 
both manic type: (ICD-10: F25.0, F30.2: schizoaffective disorder- manic type; manic 
episode with psychotic features) and ‘depressive type: (ICD-10: F25.1, F32.3: 
schizoaffective disorder- depressed type; major depressive episode with psychotic 
features). OPCRIT also provided DSM-IV diagnoses which were used to classify 
diagnostic groups in this study. 
The Beck Cognitive Insight Scale: BCIS (Beck, Baruch, Balter, Steer, & Warman, 
2004) 
The Beck Cognitive Insight Scale is a self-report questionnaire measured on a 
four-point Likert scale from 0 (do not agree at all) to 3 (agree completely) which was 
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modified to a seven-point Likert scale in this study to match a previous FEP study 
(O’Connor, et al., 2013) (see appendix E). This scale consists of two psychometrically 
distinct factors: a 6-item self-certainty scale (SC: range 6 to 42) and 9-item self-
reflective scale (SR: range 9 to 63).  The two scales can be examined separately or can 
be combined to examine a Cognitive Insight composite score (self-reflective score 
minus self-certainty; range -33 to 57).  No time frame is provided for this measure.   
The two factor structure of the BCIS, as advocated in the original scale 
publication paper, has been replicated in seven other studies (Riggs, et al., 2010) 
including an FEP sample (Tranulis, et al., 2008).  Confirmatory factor analysis 
conducted in this study sample suggests that factor loadings for both constructs were 
equivocal to the original item loadings (Beck, et al., 2004) and the two factor model 
reached statistical significance (t-ratio >1.96) (Wang & Wang 2012).  Cronbach’s α for 
the self-certainty scale was 0.76 with item-total correlations ranging from .61 to .72, p 
<001.  The coefficient α for the self-reflective scale in this study was 0.71 with item-
total coefficients ranging from .35 to .69 p <001.  Item 14 from the SR scale “there is 
often more than one possible explanation for why people act the way they do” had the 
lowest correlation with scale total (r=.35).  Interestingly, this is also the only item of 
the scale which requires participants to reflect upon other persons, whereas other SR 
items evoke reflection about one’s own thoughts and behaviour.  It may be that this 
item taps into aspects of ToM (a meta-cognitive construct described in the 
introduction), which has lowered its correlation with other self-reflection items.  
However, the removal of item 14 had a minimal impact upon the coefficient α of this 
scale (changed from .71 to .72) so in order to maintain validity and comparability to 
other studies, the decision was taken to retain this item in the data-set.  The internal 
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consistencies for the BCIS scales in this study are higher than the consistencies 
reported in the original publication paper which were: α=.60 for SR and α=.68 for SC 
(Beck, et al., 2004).   
Other psychometric properties of this scale (including construct validity, 
criterion validity, test-retest validity, convergent and discriminant validity) have been 
examined and deemed adequate across many studies including FEP samples (Lepage,  
et al., 2008; Tranulis et al., 2008: See Riggs, et al, 2012 for comprehensive review).  
This measure has also been translated into a number of different languages and shows 
cross cultural applicability(Carlson, et al., 2009; Kim, Jhin, Chung, Chang & Lee, 
2007; Engh, et al., 2007;Favrod et al., 2008; Uchida, et al., 2009).  No normative 
population scores or clinically relevant cut-offs have been established or 
recommended for the BCIS measure. 
The Probabilistic Reasoning Beads Task (Huq, Garety, & Hemsley 1988). 
This task has already been outlined in the first chapter (see reasoning processes 
section) and a full outline of the instructions and experimental paradigm is provided in 
appendix F.  This study used the 15:85 ratio version of this task.  The decision to use 
this version rather than the 60:40 ratio was informed by concerns that the latter 
version is more difficult (Dudley, et al., 1997) and may index lower-order cognition 
rather than reasoning processes per se (Moritz & Woodward, 2005).  The possible 
number of beads drawn before an individual makes a decision of certainty ranges from 
1 to 20.  To optimise consistency, the administration was computerised and standard 
written instructions read and shown to participants: each slide presented all the 
information required for all stages (i.e. two jars, jars with mixed beads, 1st selected 
bead, 2nd selected bead etc.).  Instructions were always read out verbatim, at a 
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measured pace, and researchers verified participant understanding with each slide 
presentation.  The task was not administered if the participant was unable to show 
understanding of the instructions. 
The ‘draw to decision’ (DTD) measure was used to identify a JTC bias in this 
study, as this measure has been shown to be most reliably associated with delusions 
(Fine, et al., 2007; Garety, et al, 2005).  A tendency to ‘Jump to Conclusions’ (JTC) 
was operationally defined as the respondent making a decision after two beads or 
fewer as has been used in other FEP studies (Dudley et al., 2011; Falcone et al., 
2014).  Studies support the superiority of this categorical definition over continuous 
measures.  For instance, continuous measures are not normally distributed and a 
categorical version is shown to be better related to symptom change (Garety et al., 
2005; So, et al., 2012).   
The Wechsler Adult Intelligence Scale -Third Edition: WAIS III (Wechsler, 1997). 
 Full-scale IQ was extrapolated from the Wechsler Adult Intelligence Scale – 
Third Edition.   This instrument was used because of its wide applicability and use in 
research and clinical settings.  Version III was the most up to date at the time that 
participant recruitment began in the GAP project.  A short version of WAIS III was 
adopted and included the following subtests: Information, Digit Span, Block Design, 
Matrix Reasoning and Digit Symbol Coding.  These scores were averaged within their 
domain and multiplied by the total number of WAIS III subtests in each domain to 
approximate an individual IQ score; using short-forms of WAIS is common in 
psychosis research to estimate full scale IQ (Holthausen, et al., 2007; Leeson, et al., 
2009; Missar, Gold & Goldberg, 1994; O’Connor, et al., 2012).  These particular 
subtests were chosen because they index a wide range of cognitive abilities, including 
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all relevant IQ domains (verbal comprehension and working memory, perceptual 
reasoning and processing speed).   
The reported psychometric properties of these IQ subtests are taken from the 
WAIS III technical manual (Wechsler, 1997).  Correlations between subtest and full 
scale IQ are strong: (Information r=.81, Block Design r=.73, Matrix Reasoning 
r=.75).  The Digit Symbol coding and Digit Span subtests have slightly lower 
correlations with full scale IQ (r=.61) although were still included in the battery 
because they represent lower-order cognitive functions sensitive to psychosis-related 
pathology (Leeson, et al., 2008: Saykin, et al., 1994).  Reliability coefficients for these 
sub-tests have been calculated based on item scores from a single administration, 
divided to form two half tests from and corrected by the Spearman-Brown formula.  
The Digit Symbol Coding task is a timed task, so test-retest reliability was calculated 
instead of a half-split coefficient.  Reliability coefficients of these subtests, for the age 
ranges relevant to this study (18 to 65) are as follows: Information, Matrix reasoning 
and Digit Span  =.90 and above ; Block Design coefficients ranged from .85 to .90; 
and Digit Symbol Coding ranged from .81 to .86.  A sub-group of researchers 
(including the author) were trained in WAIS administration and scoring, with guidance 
from the senior neuropsychologist advisor in the team.  All researchers administering 
neuropsychological measures were required to pass a practical administration test 
before given authorisation to complete this assessment with participants. 
Figure 2 illustrates the administration of all measures used in this study over 
the three study-points.  Procedures around study recruitment and completion of study 
measures will be described in the next 
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section.
 
Figure 2: Timeline for the collection of measures.   
 
Procedure 
The following section will describe the procedures as they apply to the 
different phases of this thesis project, including recruitment of participants, 
completion of baseline measures (Time 0) and completion of follow-up measures 
(Time 1 and Time 2).   
Recruitment 
During the Time 0 assessment period (Jan 2006 to May 2011) a weekly screen 
of the electronic-Patient Journey System (ePJS) was carried out to identify all new 
FEP cases accepted into psychiatric wards and community mental health teams in the 
catchment area.  Eligibility was largely determined by reading medical entries from 
the electronic records and supplemented by regular communication with service 
doctors, nurses and healthcare assistants, who also provided important information for 
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risk assessment.  Participants aged between 18 and 65 as per inclusion criteria were 
identified as eligible, and if deemed appropriate following risk assessment, were 
approached as soon as possible.   
A GAP researcher introduced themselves and the study to eligible individuals 
and provided written information about the study (see appendix G).  Once the patient 
had carefully read all aspects of the information and consent sheet, and if the patient 
was amenable, written consent was taken during this first encounter.  In situations 
where participants were undecided or did not understand the research, they were 
approached again at a later date (with their permission) to gain consent (up to a 
maximum of 6 months after first contact with services).  In many instances, 
researchers met with participants on several occasions to ensure they had the capacity 
to understand the study before written consent was obtained.  All participants were 
made aware that participation was voluntary and that they could refuse re-approach or 
withdraw from the study at any point without indicating reason and without impact on 
their ongoing clinical care.  Approximately 44% of eligible individuals who were 
approached to participate in this study refused to take part.  According to a qualitative 
study which assessed recruitment processes in the GAP project, reason for refusal was 
highly variable and included: lack of acceptance of psychosis label; fears about the 
impact of partaking on their health; concerns about confidentiality; the influence of 
other inpatients; and inappropriate timing of when they were approached (Woodall, 
Howard & Morgan, 2011).   
Time 0 assessment procedures 
Once participant consent was agreed, baseline assessments were arranged.  
These assessments were carried out on the ward if a patient was under admission, at 
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the research office base at the Institute of Psychiatry; or within their community 
mental health service office.  While most patients recruited into this study were 
inpatients at the time that consent was obtained (79.8%), Time 0 assessments usually 
occurred once participants left hospital, and their mental health had stabilised.  This 
flexible window for data collection was necessary given that participants were often 
highly symptomatic at study entry and commonly experiencing great distress about 
their circumstances.  There was variability in the sequence of administered 
assessments and length of time that the battery of tasks took to complete.   
Time 1 and 2 follow-up assessment procedures 
During Time 0 assessment, permission was sought for participants to be 
contacted at a later date to repeat some measures, and to contact the participant’s 
healthcare providers to gather information about their recovery progress.  A sub-team 
of researchers from the GAP project, including this author, were responsible for 
contacting participants and arranging follow-up assessments.  Researchers used 
contact numbers given by participants at Time 0 and/or sent letters to their home 
address to invite participants to be involved in the follow-up component of the study.  
If participants were agreeable, appointments were arranged, at which, research 
information sheets were given to participants and written consent obtained again (see 
appendix G).  During interviews with clients, researchers rated GAF symptom and 
function based on participant self-report and presentation at interview.  If clinical 
notes were available within the one month time-frame of interview then clinical 
records were also taken into account for GAF ratings.   
Assessments were arranged within the Time 1 and Time 2 follow-up window, 
as indicated in Figure 2.  The time windows used in this study for follow-up were 
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broadly informed by prior illness course literature which considered short-term 
follow-up to range between 6 months to 2 years post FEP and medium-term follow-up 
between 3 to 7 years post illness onset (Allott, et al., 2011; McGlashan, 1988).  Figure 
2 shows the actual follow-up ranges achieved in the study.  The same Time 1 and Time 
2 data collection windows were applied to assessment measures completed via clinical 
records.  While wide follow-up windows were set, researchers aimed to assess 
individuals as close to 12 months and five years since FEP onset as possible, to 
optimise the reporting of recovery rates across the cohort at set time-points.  However, 
patients were often followed up for less than five years for the Time 2 window 
because they were recruited later than others and the study had to be completed.  
Other patients were followed up for more than five years after FEP because of a delay 
in arranging interview.  Participants were more easily traceable for the Time 1 follow-
up and 30% were assessed within one month of the 12 month window.  However, it 
was considerably more difficult to arrange interview for the Time 2 follow-up and 
only 3.4% of participants had follow-up measures completed within one month of the 
five year follow-up window.   
When participants were not contactable or refused further participation, 
information from mental health service providers via electronic clinical records (ePJS) 
was used to complete the Time 1 and Time 2 assessment battery.  Information that was 
collected in this manner was carefully vetted for validity and bias.  For example, 
information that was available for all patients was preferentially sourced to score the 
GAF such as formal documentation (i.e. psychiatry reports, discharge summaries, 
admission/discharge summaries and Care Programme Assessment (CPA) reports).  
One tool that was also helpful for scoring the GAF was item ratings on the Health of 
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The Nation Outcome Scale (HONOS), which is the most commonly used routine 
clinical outcome measure in English mental health services (Wing, Curtis & Beevor, 
1996).   This tool contains 12 items pertaining to behaviour, impairment, symptoms 
and social functioning that can be rated by any health care professional.   
Debrief and study completion procedures 
 Following participant involvement in each stage of the research, a debriefing 
process was followed, allowing opportunity for participants to ask questions about the 
research generally, and for researchers to provide contextual information about what 
the study was hoping to achieve.  Individualised feedback to participants about their 
own responses or performance on neuropsychological measures was not provided, and 
participants were made aware of this during consent procedures.  Researchers were 
trained to signpost participants to where to receive local support when emotional 
distress was indicated during assessment (i.e. to contact care coordinator if they were 
supported by secondary care or to contact their GP in cases where participants were 
discharged from metal health serviced, Samaritan help lines or A&E as deemed 
appropriate).  Participants were provided with a study email address to be able to 
contact the study administrators to withdraw their participation from this research or 
to seek further information about the study.  Newsletters were disseminated to 
participants through the post, outlining research findings from the broader GAP 
project.   
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RESULTS 
Overview 
This chapter outlines the data screening procedures and descriptive statistics 
for the study sample.  This is followed by an exploration of the psychometric 
properties of the main outcome measure (GAF symptom severity and general 
function).  Next, the relationships between key measures are examined through 
correlation analyses.  This correlation analysis informed the author as to which 
variables to choose for regression models and clarified the relationships between the 
cognitive variables.  Finally, the main findings in relation to study hypotheses are 
described.   
Data Screening  
Outliers  
Visual inspection of box-plots helped to identify data entry errors or otherwise 
extreme outliers that may have exerted influence upon the descriptive data figures.  
Extreme outliers were defined as any score on a continuous measure that deviated 
three times the length of the 25-75% quartile range, as measured from the inner hinge 
of the visual box plots (Gray & Kinnear, 2012).  Only the ‘hospital admissions 
variable’ contained extreme outliers (three) and these cases were retained in the data-
set for the following reasons: a) these cases were legitimately representative of 
population data (some participants did spend majority of follow-up time as psychiatric 
inpatients; b) removal of these outliers did not assist in normalising the distribution of 
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the admission days variable (see distribution section).  Non-extreme outliers (defined 
as data 1.5 times the length of the inner quartile range) were found in other variable 
data-sets (two in PANSS positive and one in the BCIS composite index).  However, 
these data were also retained in the data-set as the sample size was considered robust 
enough to prohibit deviant scores from having a large impact upon the overall 
variance and shape of the measure distributions (Gray & Kinnear, 2012). 
Distributions  
The distribution of each continuous measure used in this study was inspected 
to decide whether these data were suitable for parametric statistics.  Normality was 
assessed using measures of kurtosis and skew and by consulting histograms.  A 
symmetrical and bell curved distribution of scores was assumed if z scores on these 
measures of normality were < 2.58 (Field, 2009). 
 The two subscales examined in the Beck Cognitive Insight Scale measure 
(self-certainty and self-reflectivity) were examined separately and in combination 
(Cognitive Insight composite index).  All three components of this instrument showed 
a symmetrical spread of scores.  Tests of normal distribution were conducted on all 
other continuous variables used in this study, including GAF symptom and function 
scores across the three time points, PANSS measures, the IQ index and number of 
inpatient admission days over the five year follow-up period.  PANSS positive and 
PANSS negative scores both showed a significantly positively skewed distribution 
(z=2.81, p<0.01 and z=2.66, p<0.01 respectively).  A square root transformation was 
carried out on these measures, which resulted in a normal distribution (z=1.11 and 
z=1.44 respectively).  The data for number of inpatient admission days was also non-
normal, showing a positive skew (z=14.11, p<0.01) and flattened distribution (z=7.13, 
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p<0.01).  This highly positive skew may be a result of a large portion of participants 
(48.8%) experiencing no further psychiatric admissions following their first episode of 
psychosis.  This variable was transformed using log 10 (skew z=-0.91, p>0.01; 
kurtosis z=0.54, p>0.01) and this transformed variable was used for parametric tests 
of association. 
Missing data 
 The clinical nature of this study meant that participants were often highly 
symptomatic at study entry, and in addition to a very lengthy GAP assessment battery, 
there is consequently some variation in completion rates for individual measures.  
Completion rates for each individual measure varied from n=101 to 111.  Reasons for 
incomplete measures were identified as researcher error or participant refusal to have 
particular measures administered.  No systematic imputation for missing data was 
conducted, as the sample size was large enough to withstand data omission and still 
detect true relationships in the data (minimum required sample size of 80).  This is 
with the exception of one case item omission from the BCIS self-reflective scale, 
whereby a single mean imputation solution was deemed appropriate (as scale was 
normally distributed) to replace one missing item score (Clark-Carter, 2009).  Attrition 
rates at follow-up are described in the next section.   
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Sample Characteristics  
Response Rate and Attrition  
 Reasons for attrition at each study time point, as well as a breakdown of those 
seen for face to face interview and those assessed via clinical records, are provided in 
Figure 3.The total Time 1 follow-up sample was 95 participants.  The total Time 2 
sample was 90 participants, and was inclusive of four people who were un-contactable 
during the Time 1 assessment window and re-entered the follow-up cohort for Time 2.  
The average follow-up time for Time 1 was 11.5 months (sd=2.2, range 7-24 months) 
after Time 0 assessment.  The average time for Time 2 follow-up was 49 months, or 
just over four years (sd=11.5, range 27-86 months).  By Time 2 follow-up, 18.9% of 
the eligible cohort had become untraceable.  Efforts were made to contact GPs to gain 
rudimentary information on missing participants, such as whether the participant had 
died or emigrated.  This information is also presented in Figure 3.   
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Figure 3: Flowchart indicating follow-up methodology and attrition rate 
Missing from follow-up cohort (n=12) 
 
Un-contactable and discharged from mental 
health services and GP, n=3 
 
Migration overseas, n=4 
 
Migration to other parts of the UK, n=3 
 
Non-suicidal death, n=2 
 
 
 
Missing at Time 1 (n=4) 
 
Un-contactable and discharged from 
services, n=4 
 
 
Missing at Time 2 (n=9) 
 
Un-contactable and discharged from 
services, n=7 
 
Suicide, n=2 
 
 
 
 
Eligible for follow-up 
n=111 
 
Follow-up assessment 
complete n=99 
 
Time 1 follow-up sample 
n=95 
 
GAF scored at face to face 
interview (n=40) 
 
 
GAF scored via clinical 
records (n=55) 
 
Time 2 follow-up sample 
n=90 
 
GAF scored at face to face 
interview (n=46) 
 
 
GAF scored via clinical 
records (n=44) 
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Analysis was carried out to examine Time 0 variable scores for participants 
who were traceable at Time 2 follow-up (n=90) compared with participants who had 
dropped out of the cohort by Time 2 (n=21).  This analysis was carried out using 
independent t-tests for continuous data and chi square for categorical data.  Equal 
variation within these groups was assumed for all Time 0 variables except one (Time 0 
negative symptoms), where appropriate non-parametric statistics were used.  Table 1 
compares the sample characteristics of those retained at follow-up with those of 
participants missing at follow-up.  This was necessary to establish whether attrition 
was at random, or whether systematic bias was operating in the Time 2 sample (Rubin, 
1976).  These findings suggest that there are no significant differences between those 
who were traceable for follow-up assessment and those who had become untraceable 
at Time 2, with the exception of baseline GAF scores.  In terms of this variable, those 
who were un-traceable at follow-up had significantly more psychopathology at Time 0 
than those participants who were seen for follow-up t(109)=-2.461, p=0.015.   
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Table 1: Comparison of the Time 2 sample vs. sample missing at follow-up 
 
Total eligible (n=111) Retained at 
Follow-up 
(n=90) 
Lost at 
Follow-up 
(n=21) 
Statistic Sig 
Age  
Median (sd) 
29.44 (9.12) 31.47 (11.67) t (109)=.919 0.437 
BCIS Composite  
Mean (sd) 
14.33 (14.05) 12.86 (13.55) t (109)=-.436 0.664 
PANSS Total  
Mean (sd) 
58.23 (14.67) 64.12 (12.75) t (99)=1.501 0.137 
GAF symptoms  
Mean (sd) 
50.58 (20.22) 38.75 (15.37) t(109)=-2.461 0.015 
GAF function  
Mean (sd) 
57.98 (16.97) 55.50 (17.16) t(108)=-.591 0.555 
IQ  
Mean (sd) 
90.39 (15.34) 89.57 (13.58) t(99)=-.212 0.833 
Gender  
Male (%) 
63.3% 61.9% (χ2 (1) =-144 0.704 
JTC Bias Present  
Yes (%) 
45.9% 52.6% (χ2 (1) =.284 0.594 
Diagnosis 
Non Affective psychosis 
(%) 
 
57.8% 
 
71.4% 
 
(χ2 (1) =1.33 
 
0.250 
Ethnicity  
White British or 
European (%) 
 
34.4% 
 
23.8% 
 
(χ2 (1) =.879 
 
0.349 
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Sample demographics 
 Demographic data is described for the sample that completed at least one 
follow-up at either 12 months or five years following first-episode psychosis (n=99).  
The majority of participants were male (62%) and the median age was 28 years 
(sd=9.1, range 18-58).  Each participant assigned themselves to a racial/ethnic group 
and these were then collapsed into the five following categories: White British 
(25.3%), Black African (24.2%), Black Caribbean (17.2%), White European (9.1%), 
Mixed Race (10.1 %), Asian (10.1%) and other (4%).  The majority of this sample 
(60%) grew up and were educated in the UK.  Further socio-demographic information, 
as collected at Time 0 can be found in Table 2.
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Table 2: Socio-demographic information
Variable Cohort with follow-up data (n=99)  % 
   
Level of education 
Obtained 
Postgraduate 
 
Degree 
 
A Levels 
 
NVQ/Vocational qualification 
 
GCSE’S 
 
No qualifications 
2.1% 
 
16.0% 
 
23.4% 
 
23.4% 
 
19.1% 
 
16.0% 
 
Living/ Housing Status  
 
Alone  
 
Alone with Children  
 
With Partner  
 
With Partner & children  
 
Parents  
 
Other Family  
 
Friends  
 
Other  
 
37.4% 
 
7 % 
 
2% 
 
9.1% 
 
29.3% 
 
2% 
 
8.1% 
 
5.1% 
 
Employment Status  
 
Unemployed  
 
Student  
 
Employed Full Time  
 
Employed Part Time  
 
61.6% 
 
9.1% 
 
17.2% 
 
12.1% 
 
Relationship Status 
 
Single  
 
Married/living with someone  
 
In a steady Relationship  
 
Divorced, separated  
 
Widowed  
 
72.7% 
 
14.1% 
 
10.2% 
 
2% 
 
1% 
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 Sample clinical characteristics  
 Clinical data is described for the sample that completed at least one follow-up 
at either 12 months or five years following first-episode psychosis (n=99). 
Participants were classified into eight different diagnostic categories, as reported in 
Table 3.  The most common diagnosis at first-episode was schizophreniform disorder 
(29.3%).  These figures were then collapsed into a binary diagnosis variable to 
compare non-affective with affective psychosis diagnoses, as evidence suggests that 
diagnoses can have an impact upon recovery outcomes in psychosis (Bromet, et al., 
2005; Riechler-Rossler & Rossler., 1998).  The majority of participants in this sample 
(59.6%) were classified as having a non-affective diagnosis.  Table 3 also describes 
the symptom severity of participants at Time 0.  The threshold for clinical levels of 
symptoms using the PANSS is widely accepted to be >3 for each rating scale item 
(rating scale of 1 to 7) (Kay, et al., 1987), which means that a score of 21 + on the 
positive and negative scales (i.e. a score of 3 or more on each of the 7 items) would 
indicate that participants’ were clinically unwell at the time of assessment.  The mean 
positive and negative symptom scores suggest that participants were below clinical 
thresholds in terms of psychosis, at the time of assessment.  The mean PANSS total 
for this sample is 15 points lower than the reported mean score in one previous FEP 
sample examining the BCIS (Tranulis, et al., 2008), but is commensurate with a 
different FEP study sample that examined the BCIS (Buchy, et al., 2009).  The mean 
GAF symptom score at Time 0 (where higher scores indicate fewer psychiatric 
symptoms) was in the mild range and is in agreement with the scale authors’ 
expectations for outpatient status (Endicott, et al, 1976).  The range of days spent as a 
psychiatric inpatient varied widely for the first year following FEP from 0 to 365 
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days, and the median time spent in hospital over the first year was 32 days (sd=76.84; 
range 0-365 days).  The median number of days spent as a psychiatric inpatient over 
the five years was 76 days (sd =220; range 0-1,406 days). 
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Table 3: Clinical characteristics of the sample   
 
 
 
Research Diagnoses: DSM IV  n=99 
Schizophreniform Disorder  
 
29 
Manic Episode with Psychosis 17 
Schizophrenia 16 
Psychosis Not Otherwise Specified 13 
Major Depression with Psychotic Features 10 
Schizoaffective Disorder Depressed  9 
Schizoaffective Disorder-Bi Polar 4 
Delusional Disorder 1 
PANSS (n=93) Mean (sd) 
PANSS Positive  14.4 (5.4) 
PANSS Negative  15.0 (6.2) 
PANSS General  
 
29.7 (7.0) 
PANSS Total  58.7 (14.  5) 
GAF (n=99)  
Symptoms  48.9 (20.3) 
Function  57.4 (16.9) 
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Sample cognitive characteristics 
 Table 4 provides the descriptive data relating to the main measure in this study 
(BCIS composite score) as well as the two subscales that make up this measure (self-
reflection and self-certainty).  On the self-reflection scale, the median score fell very 
near to the mean score of 38 (sd=3.9) in a possible range of 7 to 63.  Responses on the 
self-certainty scale also showed a mean equal to the median, in a possible range of 
scores of 7 to 42.  Descriptive data for other cognitive measures collected in this study 
are also described.  The mean IQ score was in the low-average range when compared 
to population norms, and this is commensurate with previous FEP findings (Carlsson, 
et al., 2006).  Individuals with IQ scores <70 were included in analysis (n=6), given 
that very low IQ scores have been described in other FEP studies (Leeson, et al 2011; 
O’Connor, et al., 2012; O’Connor, et al., 2013).  IQ distributions were normal with 
the inclusion of participants with very low poor IQ performance (<70) and main 
findings were also unchanged when these cases were excluded.  A large minority of 
this sample (47%) showed the JTC bias as according to a <3 beads threshold, which is 
the same proportion of participants found to show this bias in a different FEP sample 
that used the same draws to decision threshold (Dudley, et al., 2011). 
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Table 4: Descriptive data for cognitive measures 
 
Cognitive Measures Mean SD Range 
BCIS composite 14.63 14.07 -25 to 43 
BCIS Self-Reflection 38.76 9.71 17 to 57 
BCIS Self-Certainty  24.13 8.03 11 to 42 
IQ 90.69 15.35 58 to 128 
JTC Beads Task*  4.79 5.15 1 to 20 
    
* Descriptive data represents draws to decision on the Beads Task 
 Follow-up Data Quality  
Given the two methodologies used to assess GAF, psychometric analyses were 
conducted to assess whether GAF ratings collected via clinical records alone were 
consistent and valid compared to GAF collected via clinical interview. 
Inter-Rater Agreement 
The usual manner for GAF to be collected in this study, over the three study 
time points, was via interview.  In situations where participants were not available for 
interview, GAF was rated via clinical records.  These assessments were completed 
independently by multiple researchers across Time 1 and Time 2.  To ensure that GAF 
scores rated via clinical records were completed in a consistent manner during follow-
up, the author and the three other researchers involved in data collection via clinical 
records (referred to here as coder a, coder b, coder c and coder d) conducted a 
reliability analysis.  This required each researcher to re-rate a random sample of 
clinical records to independently score GAF-symptoms (GAF-S) and GAF-function 
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(GAF-F).  Each clinical record was twice rated by different researchers, blind to each 
other’s rating.  A ‘not fully crossed’ design was used as per recommendations when 
multiple coders have been involved in ratings (Hallgren, 2012) and Intra-Class 
Correlations (ICC) between researchers were calculated.  The number of participants 
chosen for this exercise was 15, based on textbook recommendations that 15-20 
subjects are adequate for such purposes using a continuous variable (Fleiss, 1986).  
This resulted in 30 separate duplicate scores (GAF symptom and function score for 
each participant) for which intra-class coefficients were calculated.  This reliability 
exercise took place at Time 1 and again at Time 2.  Coder a (author) was involved in 
this exercise for both Time 1 and Time 2.  Coder b and c were involved in Time 1 
follow-up scoring and coder d was involved in the Time 2 follow-up ratings only.  All 
coding pairs achieved excellent intra-class correlation > 0.90 (Cicchetti, 1994) 
indicating that there was a high degree of agreement when independent GAF ratings 
for the same participant were compared (See Table 5 for the paired reliability 
coefficients from these analyses). 
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Table 5: Inter-rater agreement for GAF ratings from psychiatric clinical records 
 
 GAF SYMPTOMS  GAF FUNCTION 
 Coder A Coder B  Coder A  Coder B 
Subject 1  
 
ICC=1.000 
 
 
ICC=.997 
 
Subject 2 
Subject 3 
Subject 4 
Subject 5  
 Coder B Coder C Coder B Coder C 
  
 
 
ICC=.987 
 
 
 
ICC=.997 
Subject 6 
Subject 7  
Subject 8  
Subject 9 
Subject 10 
 Coder A  Coder D Coder A Coder D 
Subject 11  
 
ICC=.917 
 
 
 
ICC=.995 
Subject 12 
Subject 13 
Subject 14 
Subject 15 
 
ICC = intra-class correlation 
 
   
 It was also necessary to measure the consistency of GAF scores rated from 
clinical records alone compared with GAF scores rated primarily through direct 
clinical interview.  For this exercise, duplicate GAF ratings were independently rated 
for 25 participants (approximately 30% of Time 2 sample).  This figure was the 
number of participants who had a clinical interview at Time 2 follow-up and also had 
detailed clinical records within the same one-month period as interview.  This author 
(Coder A) generated a GAF score for symptoms and a GAF score for function via the 
clinical records only, blinded to the GAF rating scored based on direct clinical 
interview  within the same time period by another researcher (Coder E) .  An intra-
Class Correlations (ICC) between Coder A and Coder E  was calculated and suggests 
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that GAF scores collected from clinical records and  GAF scored via face to face 
interview showed high comparability (ICC=.81) (Cicchetti, 1994) 
 
Correlation Analysis  
Table 6 reports the preliminary analyses of Pearson’s and point bi-serial 
correlations (when 1 variable was binary) were conducted for two purposes.  The first 
purpose was to examine relationships between all Time 0 potential confounders with 
the dependent variables (DV: GAF symptoms and GAF function at Time 2).  It was 
important to account for these relationships before examining the unique main effects 
of the independent variable in this study (IV: BCIS Cognitive Insight).   The second 
purpose of correlation analysis was to investigate relationships between cognitive 
variables, to determine whether the BCIS measure is distinct from IQ and the JTC 
bias, and whether the BCIS subscales correlate differently with these cognitive 
measures.  No corrections for multiple comparisons were applied to these analyses for 
the following reasons: a) this analysis was exploratory in nature and not hypotheses-
driven;  b) given that the nature of these analyses was to identify potential 
confounders, the risk of type II errors (false negative associations) outweighed 
concerns about type I errors (false positive correlations).  The risk of Type I errors was 
instead reduced by using the size of the correlation as an indicator of value, rather than 
relying purely on significance testing.  Only correlations that were significant at the 
p<.01 and of greater magnitude than .25 were entered into subsequent regression 
modelling, as per prior recommendations (Cohen, 1992).
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Table 6: Correlation Matrix  
Pearson’s and point bi-serial correlations between possible cognitive, clinical and demographic confounders 
 
**Correlation is significant at <0.01 level (2-tailed) a affective vs.  non-affective psychosis b white British/European vs. other.
 BCIS CI BCIS SR BCIS SC 
GAF T2 
Symptoms 
GAF T2  
Function 
GAF T0 
Symptoms 
GAF T0 
Function 
Admission 
Days 
PANSS P PANSS N PANSS G Diagnosisa JTC Bias IQ Gender Ethnicityb Age 
UK 
educated 
BCIS CI 1.00                  
BCIS SR .834** 1.00                 
BCIS SC -.744** -.251 1.00                
GAF T2 
Symptoms 
.151 .237 .021 1.00               
GAF T2 
Function 
.270 .218 -.214 .668** 1.00              
GAF T0 
Symptoms 
.035 -.099 -.179 .040 .158 1.00             
GAF T0 
Function 
.255 -.298** .121 .204 .414** .566** 1.00            
Admission 
Days 
-.165 -.210 .044 -.121 -.143 .071 .057 1.00           
PANSS P -.331** -.158 .391** -.136 -.303** -.304** -.388** .145 1.00          
PANSS N -.175 -.155 .120 -.320** -.329** -.329** -.214 .091 .133 1.00         
PANSS G -.212 -.085 .271** -.104 -.226 -.236 -.224 -.027 .522** .402** 1.00        
Diagnosisa .091 .019 -.137 .294** .297** .075 .158 -.168 -.047 -.257 -.017 1.00       
JTC Bias .164 .029 -.313** -.142 -.054 .185 .200 -.193 -.249 -.064 -.129 .034 1.00      
IQ .206 .033 -.258 .097 .226 -.097 .115 -.131 -.124 -.303** -.174 .106 .229 1.00     
Gender .132 .142 -.060 .119 .311** -.125 -.063 -.099 -.093 -.141 -.008 .112 .082 .110 1.00    
Ethnicityb -.296** -.244 .244 -.164 -.392** -.157 -.180 .159 .144 .065 .052 -.116 .024 -.285** -.147 1.00   
Age -.035 -.020 .038 -.096 -.038 .027 -.090 -.277 -.031 -.171 -.055 .080 -.004 .011 .003 -.011 1.00  
UK educated -.127 .004 .226 .097 -.068 .136 .201 .038 .050 .000 .015 .035 -.209 -.286** -.100 .320** .038 1.00 
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Identifying confounder variables 
GAF symptom scores at Time 2 follow-up were significantly correlated with 
Time 0 negative symptoms and diagnosis, such that less-severe negative symptoms 
and an affective diagnosis at psychosis onset was associated with decreased 
psychopathology at five year follow-up.  The number of psychiatric admission days 
during follow-up did not correlate with any other Time 0 factors (including cognitive 
variables) to a significant p<0.01 level. Therefore, this measure was not used as a 
dependent measure of illness severity.  
GAF function at Time 2 correlated significantly with six Time 0 variables 
including: GAF function, ethnicity, gender, negative symptoms, positive symptoms 
and diagnosis.  Specifically, better social and vocational function at five years was 
associated with better functioning at study entry, being white, female, having less 
severe negative and positive symptoms at onset and having an affective psychiatric 
diagnosis. 
Relationships between cognitive variables  
The self-reflective scale (SR) and the self-certainty scale (SC) scales were 
negatively correlated, such that those who scored high on the self-reflective items of 
the BCIS scale also scored low on self-certainty items.  However, the strength of this 
correlation was weak (Cohen 1992).  Analysis also showed that the two subscales 
related differently to other cognitive variables measured in this study.  The self-
certainty scale had a significant, though weak correlation with the JTC variable, such 
that higher self-certainty was associated with a tendency to jump to conclusions.  The 
self-certainty scale was also significantly correlated with IQ.  JTC response and IQ 
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were correlated, such that lower IQ was associated with increased endorsement of the 
JTC bias (a tendency to jump to conclusions).  Neither IQ nor the JTC measure was 
significantly correlated with the BCIS self-reflective scale.  
Main Findings 
Hypothesis 1 
 Cognitive Insight (as measured by BCIS composite score) will predict medium-term 
(five-year follow-up) symptom severity after controlling for the JTC bias.   
 A hierarchical multiple regression was conducted with GAF symptoms at five 
years as the dependent variable and the BCIS composite score as the independent 
variable (IV).  Other variables that were highly correlated with the dependent variable 
(DV) were also entered into the regression model (negative symptoms, diagnoses).  
The aim of this analysis was to determine how predictive the BCIS composite score 
(Cognitive Insight) was, after accounting for the effects of other significant Time 0 
variables.  Against expectations, the JTC variable did not correlate to a significant 
level with symptom severity at Time 2 (r= -.142, p= -.197) and therefore was not 
entered into this predictor model.   
 Data used in this analysis conformed to the multi-collinearity requirements for 
regression analysis.  Collinearity of predictor variables was low (tolerance >0.9), 
indicating that 90% of variance in the predictor variable, was unique to individual 
variables entered.  To further protect against multi-collinearity, only variables with DV 
correlations significant at the <0.01 level, at a magnitude at >.25 were entered into the 
model.  Visual inspection of residual and scatter plots suggests that assumptions of 
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normality, linearity and equality of variances were met and no unusual data exerted 
undue leverage to the model (Cook‘s largest d=.111) (Cook &Weisberg, 1982).  
Negative symptoms (PANSS) and diagnosis (affective vs. non-affective) were entered 
together in step 1 as they both represent clinical predictors of outcome in the FEP  
literature (Menezes, et al., 2006).  The IV (BCIS composite score), was entered in the 
second step of the regression.  This predictor model was significant and negative 
symptoms, diagnosis and the BCIS composite score, accounted for approximately 
15% of variance in medium-term symptoms severity F(3,79)=4.797, p=0.002.  The 
addition of the BCIS composite score at Step 2 accounted only for 0.6% of variance 
which was not a significant contribution to the model F(3,79)=.585 p=0.447 R2=.148, 
adjusted R2=.115).   
Post-hoc analyses were carried out to examine the effects of the BCIS 
subscales separately, in light of their differential correlates (see section: relationships 
between cognitive variables).  Therefore, another hierarchical regression model was 
created: negative symptoms (PANSS) and diagnoses (affective vs, non-affective) were 
entered at step 1, and the two BCIS scales (self-reflection and self-certainty) were 
entered together at step 2.  This overall model was significant F(4,78)=5.  258, 
p=0.046.  The BCIS subscales contributed to a significant increase in variance 
explained from 15% to 21.5% (adjusted R2 =.172).  Specifically, higher scores on the 
self-reflective scale predicted significantly better mental health function at Time 2 
follow-up (t (78) =2.324, p=.023).  The self-certainty scale did not contribute a 
significant amount of variance to symptom outcome (t (78)=1.57, p=.199).  Table 7 
reports the unique contribution of each variable entered into this model following 
post-hoc analyses.  
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Table 7: Hierarchical regression to predict symptom severity at Time 2 
aaffective vs.  non-affective psychosis 
 Std β t p 
Time 0 negative symptoms -0.247 -2.356 0.021 
Diagnoses a 0.247 2.378 0.020 
BCIS self-reflective scale 0.245 2.324 0.023 
BCIS self-certainty scale 0.167 1.577 0.119 
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 Hypothesis 2 
 Cognitive Insight (as measured by the BCIS composite score) will predict medium-
term (five-year follow-up) functional disability after controlling for IQ. 
 A hierarchical multiple regression was carried out with GAF function at five 
years as the dependent variable (DV)  and the BCIS composite score as the predictor 
variable (IV).  Against expectations, IQ did not correlate with GAF function at Time 2 
to the threshold set for inclusion into regression models (r=.226, p= 0.05).  Instead, 
GAF function correlated significantly (r>.25, p<0.01) with six other Time 0 variables, 
which were entered into this regression model.  The Time 0 variables entered were as 
follows: ethnicity, gender, GAF function, negative/positive symptoms (PANSS), 
diagnosis and the BCIS composite score.   
Collinearity of predictor variables was low (tolerance >0.75).Visual inspection 
of residual and scatter plots suggest that assumptions of normality, linearity, and 
equality of variances were met and no unusual data exerted undue leverage to the 
model (Cook‘s largest d=.083).  Variables were entered separately according to 
conceptual categories: demographic factors were entered in step 1, clinical 
characteristics and function at step 2, and the IV (BCIS composite score) at step 3.   
This predictor model was significant and accounted for 40% of variance in 
function at five years F(7,74)=6.902, p<0.001.  Demographic factors (gender and 
ethnicity) explained 19% of variance in functional disability at Time 2 F(2,79)=9.255 
p<0.001; R2=.19, adjusted R2=.169.  Another 20% of variance in functional outcome 
was explained by clinical/functional characteristics F(6,75)=8.153 p<0.001; R2=.395, 
adjusted R2=.346.  The BCIS composite score did not contribute significantly to the 
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model F(7,74)=.032 p=0.859 R2=.395, adjusted R2=.338.  Also post hoc examinations 
of the two BCIS scales separately did not make a significant difference to predictor 
model F(8,73)=.281 p=0.756 R2=.399, adjusted R2=.334. 
Individual contributions of each Time 0 variable entered in this model 
(following post-hoc analyses) are shown in Table 8.  In summary, predictors of 
decreased functional disability in the medium-term were: white ethnicity, female 
gender, less severe negative symptoms and better function at first episode. 
 
Table 8: Hierarchical regression to predict function at Time 2 
aaffective vs.  non-affective psychosis b white British/European vs.  other. 
 Std β t p 
Time 0 GAF function 0.261 2.474 0.016 
Ethnicityb -0.234 -2.414 0.018 
Gender 0.223 2.347 0.022 
Time 0 Negative Symptoms -0.196 -2.040 0.045 
Diagnosisa 0.160 1.636 0.106 
Time 0 Positive Symptoms -0.126 -1.230 0.223 
BCIS self-reflective scale 0.039 0.389 0.698 
BCIS self-certainty scale 0.070 0.700 0.486 
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Hypothesis 3  
The relationship between Cognitive Insight and symptom and functional outcome will 
be stronger in the medium-term (five-year follow-up) compared with the short-term 
(12-month follow up).   
 
Changes to GAF ratings across time 
A useful preliminary to this hypothesis was to examine whether GAF outcome 
scores changed over the three study time points (Time 0, Time 1 and Time 2) as it was 
considered unlikely that significant changes to the relationships between Time 0 BCIS 
scores and GAF outcome would be observed, if outcome itself did not change as a 
consequence of time.  Table 9 displays the mean and change statistics for GAF 
symptom and function over the three data collection time points (n=85). 
 
Table 9: Cohort’s mean GAF symptom and function scores during the study 
a approximate time frame. 
 
Time 0 
 
Time 1 
12 months a 
Time 2 
5 years a 
F Sig 
      
 
GAF: symptoms  
Mean (sd) 
 
48.90 (20.30) 56.06 (20.03) 63.79(1 6.97) 11.17 < 0.001 
 
GAF: function 
Mean (sd) 
 
57.43 (16.99) 57.78 (19.97) 61.92 (18.00) 1.774 0.173 
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In terms of GAF symptoms, a repeated measures ANOVA showed that 
symptom severity changed significantly across the three time points F(2, 168)=11.17, 
p<0.001.  Pair-wise t-tests were carried out to identify where this difference was 
located across the time points.  Compared to Time 0, symptom severity was 
significant lower at both 12 months and five year follow-up (t(94)=-2.62, p<0.001; 
(t(87)=-4.816, p<0.001 respectively).  Symptom severity at five years was also 
significantly lower than at 12 months (t(84)=-2.78, p=0.007).  By the Time 2 follow-
up at five years, the cohort mean GAF symptom score was above recovery thresholds 
for FEP (>59) (Bertelsen, et al,. 2009). 
The same statistical analysis was conducted to examine GAF function changes 
over time.  In this instance, no significant differences in GAF function was observed 
over the three time points F(2, 166)=1.77, p=.173.  However, by five years, the mean 
functional disability score for the cohort could be defined as above recovery 
thresholds for FEP (Bertelsen, et al., 2009).   
 
 BCIS correlations with recovery across time 
Table 10 shows the temporal associations between the BCIS composite score 
and BCIS subscales with GAF symptom scores.  A significant correlation was found 
between the BCIS composite score and 1 year symptom outcome (r (95) =.280, 
p=0.006).  However, by Time 2, this relationship had weakened and was no longer 
significant (r(90) =.151 (p=0.15).  T test calculations using Steiger’s Z (1980) to 
detect the difference between correlations for non- independent groups showed that 
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the difference between BCIS- recovery correlations at Time 1 and Time 2 is not 
statistically significant ZH=0.98, p=.326.   
 Post-hoc correlations were carried out on the two BCIS scales individually for 
exploratory purposes.  This analysis revealed that self-reflectiveness was significantly 
correlated with symptom outcome at 12 months and five years such that greater ability 
to self-reflect was associated with better mental health function prospectively, 
although not cross-sectionally, at Time 0.  Conversely, self-certainty did not correlate 
with symptom outcome at Time 1 or Time 2 although its relationship with symptoms 
cross-sectionally at Time 0 was nearing significance (higher self-certainty at illness 
onset was associated with greater symptom severity at onset). 
In terms of the relationship between the BCIS and functional recovery over 
time, a moderate correlation between the BCIS composite score and function was 
found at 12 months (r=.25, p=0.013) and by five years, this correlation appeared 
stronger (r=.27, p=0.010).  T test calculations using Steiger’s Z (1980) shows that this 
change in the strength of the relationship between BCIS and function is not 
statistically significant ZH=-.17, p=0.86.  Inspection of the individual BCIS subscales 
shows that the self-certainty and self-reflective scales have a different pattern of 
association with GAF function over the time-points.  Specifically, the self-certainty 
scale showed a significant cross sectional relationship with GAF function, whereas the 
self-reflection scale showed a prospective relationship with recovery. 
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Table 10: Pearson’s correlations between BCIS subscales and GAF ratings 
*Nearing significance <0.08 **significant at 0.05 *** significant at 0.01 
 
 
 
 
 
 GAF Symptoms GAF Function 
 Time 0  Time 1 Time 2 Time 0  Time 1 Time 2 
BCIS subscales       
Composite Index   .03 .28*** .15 .25** .25** .27** 
Self-Reflective items -.09 .29*** .25** .12 .25** .21** 
Self-Certainty items -.18* .14 .021 -.298*** -.142 -.21* 
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DISCUSSION  
Overview 
This study prospectively evaluated the relationship between Cognitive Insight, 
as measured by the Beck Cognitive Insight Scale (BCIS) and recovery in a first 
episode psychosis (FEP) sample.  It was expected that good Cognitive Insight (high 
self-reflectiveness, and low self-certainty) would predict better medium-term recovery 
(five years) after the onset of psychotic illness.  It was also expected that the 
magnitude of the relationship between good Cognitive Insight (a high BCIS 
composite score) and recovery would increase over time, as illness trajectories 
became more stable and discrete.  Recovery was operationalised in this study as 
symptom severity and level of functional disability, to enable relationships between 
recovery type to be examined.  In this chapter, the main findings will be considered in 
relation to Garety's cognitive model of psychosis (Garety, et al., 2001) and the illness 
course literature, which underpins the hypotheses.  Following this, the clinical 
implications of the study will be discussed.  In closing, the limitations of this study 
and recommendations for future research will be described. 
Hypothesis 1  
Cognitive Insight (as measured by BCIS composite score) will predict medium-term 
(five-year follow-up) symptom severity after controlling for the JTC bias.   
 The BCIS composite measure did not predict symptom recovery in the 
medium-term as was expected.  Post-hoc analysis of the two subscales of the BCIS 
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(self-reflection and self-certainty) revealed that only responses on the self-reflective 
scale prospectively predicted severity of symptoms in the medium-term; participants 
who endorsed highly self-reflective behaviour  (i.e. greater agreement with scale 
items such as “even though I feel strongly I am right, I could be wrong” or “some of 
my experiences that have seemed very real may have been due to my imagination”) 
had fewer and less severe psychotic symptoms at five years after psychosis onset, 
compared to those individuals who did not endorse these items.  Measures of 
confidence in judgement (BCIS self-certainty scale and JTC bias) did not contribute 
to symptom outcome at five years after FEP, though both these factors correlated 
significantly with each other, and IQ.   
These findings contradict previous studies, which found that the correlation 
between the BCIS composite score and symptom outcome is stronger than the 
correlation between self-reflective scores and symptom outcome (Bora, et al., 2007; 
O’Connor, et al., 2013; Perivoliotis, et al., 2010).  However, previous studies have 
only examined the cross-sectional and short-term prospective relationships between 
the BCIS scales and symptom outcome.  This is the first study to examine the BCIS 
and its relationship with recovery in the medium-term (3 to 7 years) after FEP and to 
show empirically a unique association between self-reflection and symptom outcome.  
This finding implies a predictive role for the self-reflective construct that has 
previously been supported in established psychosis only.  For example, findings from 
a CBT for psychosis (CBTp) trial shows that pre-treatment self-reflectiveness predicts 
positive treatment response, in terms of reduced symptoms at the end of treatment 
(Perivoliotis, et al., 2010). 
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Analysis for hypothesis 1 also revealed other illness onset predictors of 
symptom recovery.  Less severe and fewer negative symptoms at Time 0 predicted 
decreased overall symptom severity at follow-up, which replicates well-established 
findings in FEP (Huber, et al., 2008; McGlashan 1988; Ram, et al., 1992).  
Furthermore, those participants diagnosed with an affective psychosis experienced 
decreased symptom severity at Time 2 compared with participants with a 
schizophrenia-spectrum diagnosis, which is consistent with findings from a 
comprehensive review of FEP outcome studies (Bromet, et al., 2005).  All three 
significant predictor variables in this model (negative symptoms, diagnoses and self-
reflection) contributed approximately the same proportion of variance to outcome. 
Hence, they are equally valuable prognostic indicators. 
The null findings regarding the self-certainty BCIS subscale and symptom 
recovery concur with findings from previous FEP samples (Buchy, et al., 2009; 
Tranulis, et al., 2008) and are different to findings in established psychosis which 
show a positive relationship between these variables (Bora, et al., 2007: Pedrelli, et 
al., 2004).  This finding therefore supports speculation made in the introduction 
chapter (see self-certainty section) that this measure may operate differently in FEP 
than it does in established psychosis.  Only two prior studies have examined the 
relationship between the JTC bias and symptom severity prospectively in an FEP 
sample (Dudley, et al., 2013; Falcone, et al, in press), and they both found that the 
JTC bias predicted increased symptom severity, although only in cases where this bias 
is present across time.  Unlike previous FEP studies, this study found no relationship 
between the JTC bias and later symptom recovery, although this study only measured 
the JTC construct at Time 0, and not at follow-up.  Had the JTC been measured at 
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follow-up in this study, a sub-set of stable beads task ‘jumpers’ may have been 
identified, and a positive relationship between JTC and symptom outcome may also 
have been found.  However, the null findings in relation to JTC suggest it is not stable 
across the FEP population and rather both trait and state characteristics underlie this 
construct (Moritz & Woodward, 2005).  This variability underlying the JTC bias 
precludes its usefulness as an independent predictor of recovery in a heterogeneous 
FEP sample.   
This was the first study to examine the self-certainty scale alongside the JTC 
measure to predict global outcomes in FEP over time; one particularly interesting 
finding emerged with this analysis which was the converging associations between 
JTC, self-certainty and IQ (and converse lack of association between these variables 
and symptom outcome).  This provides supporting evidence that these measures are 
tapping into the same ‘confidence in judgement’ reasoning construct and also supports  
a growing body of evidence that reasoning processes are implicated by lower-order 
cognition (Falcone, et al., 2014; Lincoln, et al., 2010; Nair, et al 2014).   
Theoretical context of findings  
Garety's cognitive model (2001) proposes that meta-cognition and reasoning 
processes (both of which are, arguably, indexed by the BCIS) are involved in the 
maintenance of positive psychotic symptoms over time; and findings from this 
hypothesis are relevant to Garety’s model in two important ways.  Firstly, in support 
of the model, findings in this study provide evidence for a conceptual distinction 
between meta-cognition and reasoning processes, as the self-reflective and self-
certainty subscales of the BCIS showed separate neuropsychological and clinical 
correlates.  Secondly, in terms of which higher-order cognitive variables maintain 
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psychosis over time, results suggest that meta-cognition (self-reflectiveness) has 
better prospective value than reasoning processes (self-certainty and JTC) for 
predicting symptom outcome in FEP.  These finding challenge the recommendation in 
the original BCIS publication to yield a Cognitive Insight composite score, at least for 
the purposes of predicting prospective symptom outcome in FEP (Beck, et al., 2004).   
Hypothesis 2  
Cognitive Insight (as measured by the BCIS composite score) will predict medium-
term (five-year follow-up) functional disability after controlling for IQ. 
The BCIS composite score did not predict level of social and vocational 
disability in the medium-term, as measured by GAF function.  Nor did the subscales 
(self-reflective or self-certainty) predict function when entered into a regression 
model separately.  Similarly, IQ did not associate with functional outcome in this 
sample.  Instead, predictors of reduced functional disability over time in this study 
were: high functioning at illness onset; fewer negative symptoms; being female; and 
identifying as of white ethnic descent.  The null findings in this study between 
cognitive variables and disability suggest that functional recovery operates differently 
in FEP than in established psychosis.  Indeed, while the relationship between the 
BCIS composite score and functional outcome has scarcely been examined, a positive 
association has only ever been found in an established psychoses sample (Favrod, et 
al., 2008).  In FEP, Cognitive Insight has already been shown to have no prospective 
relationship with functional impairment in the short-term (O’Connor, et al., 2013) and 
now this study replicates these null findings in the medium-term.   
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This study accounted for IQ because of a vast literature supporting a 
relationship between this variable and functional outcome in psychosis (Green, 1996, 
Green, et al., 2000; 2004).  However closer analysis of FEP only samples reveals that 
58% of studies report no relationship between these variables (Allott, et al., 2011).  
Some studies that do identify a relationship between IQ and functional recovery in 
FEP fail to control for demographic factors (Fujii & Wylie, 2002; Jaeger & Douglas, 
1992; Yamazawa, et al., 2008).  Further, there is a significant overlap in the predictive 
power of negative symptoms and IQ in FEP (Milev, et al., 2005) and in this analysis; 
it is possible that the IQ contribution to variance in functional outcome was wholly 
accounted for by negative symptoms.   
The association between white ethnicity and better functional outcome in this 
study is consistent with literature on social adversity and psychosis.  For example, a 
large UK epidemiological study reported more risk indicators of social disadvantage 
and isolation for FEP participants of Black Caribbean ethnic background, than for 
white British FEP participants (Morgan, et al., 2008).  An adjunct analysis in this 
study did not show any association between being brought up in the UK and better 
functional outcomes in FEP. This finding suggests that the disadvantage of non-white 
ethnicity for functional recovery may not be due to barriers of language, culture or the 
impact of migration, but may be better understood as arising from actual or perceived 
discrimination in black and ethnic minority populations.  Indeed this is consistent with 
explanations of ethnic associated disadvantage in psychosis from previous studies 
(Berg, et al., 2011; Cooper, et al., 2008; Veling, Hoek., Wiersma, Mackenbach, 2009). 
  The South London catchment area in which this study was conducted is 
estimated to be populated by approximately 50-60% of black and minority ethnicities; 
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a high percentage of which are of African-Caribbean background (Office for National 
Statistics, 2012) and people who identify as African-Caribbean in the UK do report a 
higher degree of ethnic discrimination that other ethnic minorities (Cantor-Graae & 
Selten 2005; Karlsen, Nazroo, McKenzie, Bhui & Weich 2005).  That non-white 
ethnicity was uniquely associated with worse functional disability and not 
psychopathology in this study raises the possibility that different psychosis-related 
risk factors operate across ethnic populations.  For instance, despite being diagnosed 
more frequently with psychosis disorders in the UK (Fearon, et al., 2006) African-
Caribbean individuals’ with psychosis are 40% less likely than white British 
counterparts to experience continuous psychotic illness (McKenzie, et al., 2001) and 
have less enduring negative symptoms over the long term (18 years after illness onset) 
(Takei et al.,1998) .  These findings substantiate the notion that the development of 
psychosis in non-white populations in the UK might be related to increased exposure 
to social risk (i.e. paranoia tendencies because of previous discrimination, rather than 
genetic risk and developmental impairment).  Therefore, poorer socio-vocational 
outcomes observed for non-white participants in the current study may reflect broader 
social inequality, rather than disability associated with psychotic illness per se.   
The positive association found between being female and having better 
functional outcome as rated by GAF is consistent with previous FEP research (Cotton, 
et al.,2009; Faerden, et al.,2013; O’Connor, et al., 2013).  It has been suggested that 
the impact of gender can be explained by the tendency for women to be more 
commonly diagnosed with affective diagnoses (Køster, Lajer, Lindhardt, & 
Rosenbaum, 2008) which in itself has been found previously to be a predictor of good 
functional outcome (Riechler-Rossler & Rossler, 1998).  However in this study, the 
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association between female gender and better function was direct and independent of 
diagnosis.  One could speculate that the cause of this association is that women are 
better able and willing to help-seek than men.  For instance, women in the general 
population are better informed about the early signs of psychosis and pathways to care 
(Cotton, Wright, Harris, Jorm & McGorry, 2006), they have better social support 
networks at the onset of psychosis (Willhite, et al., 2008) and are more compliant with 
treatment recommendations (Thorpe, et al., 2014).  Female gender is also likely to be 
imbedded within a larger network of protective factors in psychosis.  For instance, 
help-seeking and female gender are independently known to reduce duration of 
untreated illness (DUP), which is another well-known predictor of recovery in FEP 
(Apelldorn, et al., 2014; Malla, et al.,2002b; Morgan et al., 2006).  Therefore, it is 
likely that the cumulative impact of gender-correlated protective factors, that were not 
tested in this study are likely to have compounded this positive association with 
functional recovery.   
Theoretical context of findings 
Garety’s cognitive model (2001) does not specify the role of cognition in 
determining functional disability in psychosis.  The rationale for this hypothesis was 
instead driven by the lack of research examining higher-order cognitive function and 
functional recovery in the FEP population (Alott, et al., 2011; Riggs, et al., 2012).  
The null findings in this study suggest that Cognitive Insight, IQ, or the BCIS 
subscales individually, do not predict functional recovery course in early psychosis, 
although these measures may be relevant predictors of function in established 
psychosis samples.  The overall findings from this hypothesis also highlight how 
symptom and functional trajectories are influenced by different factors and replicates 
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findings of a previous examination of this sample, which showed that cognitive 
factors predict symptom recovery, while demographic factors predict functional 
outcomes (O’Connor, et al., 2013). 
 
Hypothesis 3  
The relationship between Cognitive Insight (BCIS composite score) and recovery 
(symptom and function) will be stronger in the medium-term (five-year follow-up) 
compared with the short-term (12 month follow-up). 
A supplementary and exploratory hypothesis in this study examined whether 
the magnitude of the relationship between Cognitive Insight and recovery would 
increase over time.  Findings in relation to function and symptom recovery will be 
considered separately. 
Cognitive Insight and functional change over time  
The level of functional disability in this cohort was stable across the three 
time-points of the study, which is understandable given that stable demographic 
factors largely contributed to variance in functional outcome (see hypothesis 2).  The 
finding that GAF function is stable over time is also in agreement with meta-analysis 
of FEP outcome studies which show no proportional change in functional recovery as 
measured by the GAF, according to length of follow-up duration (Menezes, et al., 
2006).  The decision to examine change in the magnitude of the relationship between 
the BCIS composite score and function over time, was driven by the fact that this 
relationship has been examined in this sample in the short-term (O’Connor, et al., 
104 
2013) but it had never been examined in the medium-term.  Also given that functional 
trajectories can take years to stabilise after illness onset (McGlashan, 1988), it was 
speculated that relationships between these variables may change over time.  However 
no significant changes to the Cognitive Insight and function relationship emerged.  
While Cognitive Insight was significantly correlated with function at 12 months, and 
five years, these pairs of correlations were not significantly different from one 
another, and Cognitive Insight was not a significant predictor of function in regression 
modelling.  This analysis provided more conclusive evidence that higher-order 
cognitive factors are not useful prognostic indicator of functional disability in FEP.   
Cognitive Insight and symptom change over time  
Consistent with a meta-analysis of recovery in FEP (Menezes, et al., 2006), 
symptom severity decreased over time in this study.  The correlation between Time 0 
Cognitive Insight and symptom severity at Time 1 (one year after FEP) was 
significant, which replicates previous findings (O’Connor, et al., 2013).  The 
relationship between the Time 0 Cognitive Insight and symptom severity at Time 2 
(five years after FEP) was no longer significant.  However, the magnitude of the 
relationship between Cognitive Insight and symptom recovery was not significantly 
different across the two time-points.  
Through post-hoc analysis of the BCIS subscales (self-reflectiveness and self-
certainty), findings emerged which suggest a complex longitudinal relationship 
between the individual BCIS scales and recovery status.  Low self-certainty responses 
on the BCIS, showed a trend-level relationship with decreased symptom severity 
when symptoms were most acute (Time 0), and showed no prospective relationship 
with later symptom recovery.  In contrast, self-reflective scores showed no cross-
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sectional relationship with symptom outcome, and showed a prospective and stable 
relationship with symptoms over time (Time 1 and Time 2).  These findings are 
consistent with a different GAP project (using the same Time 0 sample) which found 
a significant correlation between self-certainty scores and PANSS positive symptoms 
cross-sectionally, whereas self-reflective item scores did not associate with positive 
symptoms (Wiffen, 2011).  These findings are also consistent with a similarly 
designed study, which used a symptom specific meta-cognitive measure (belief 
flexibility around current delusional ideas) to compare against a reasoning construct 
(JTC bias).  This study found that the presence of a marked reasoning bias predicted 
greater symptom severity cross-sectionally (specifically, delusional conviction), 
however over time, this association was largely mediated by meta-cognition (So, et 
al., 2012).  Taken together, these findings indicate that meta-cognitive ability such as 
self-reflection is a trait like characteristic, independent of symptom fluctuation.  On 
the other hand, reasoning processes such as ‘confidence in judgement’ are more fluid 
and perhaps influenced by the moment to moment experience of positive symptoms.   
Theoretical context of findings  
No other research study has examined whether the association between the 
BCIS and recovery varies over multiple time-points.  The impetus to do so was driven 
from the clinical stage-model, which proposes that the predictive value of variables 
may change according to the clinical phase of illness (McGorry, et al., 2010).  This 
staging model is supported by meta-analysis findings that first-order cognitive factors 
at illness onset, differentiate in their predictive capacity from short-term to medium-
term recovery phases (Alott, et al., 2011; Carlsson, et al., 2006).  The findings from 
this hypothesis support the idea that higher order cognitive constructs can differ in 
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their relationships with symptom outcome across recovery phases, such that an aspect 
of cognitive reasoning (self-certainty) has a mixed, unstable relationship with 
symptoms, whereas the ability to self-reflect might influence the endurance of 
psychopathology over time.  This finding supports the tentative supposition of 
Garety’s cognitive model, that impaired meta-cognition underlies the risk for 
psychotic symptoms, whereas reasoning processes are related to moment to moment 
appraisal of symptom experience (Garety, et al, 2001). 
Study Limitations 
This study has several limitations, specifically in relation to sampling bias, 
data collection procedures and the selection of measures.  The details of these will be 
described in the section below.   
 
Sampling and Generalisability 
 This study could be criticised for its sample heterogeneity, as this may have 
reduced the sensitivity of the study to detect relationships between key variables.  
Indeed, criteria for inclusion required only one week of psychotic symptoms, which 
resulted in eight different diagnoses across the sample, and 13% of the sample were 
ascribed with a diagnosis of ‘psychosis not otherwise specified’.  It is important to 
counter this limitation with the following points:  a) this label is still a valid 
psychiatric classification in the most recent psychiatric diagnostic manual (American 
Psychiatric Association, 2013);  b) given the criticism levelled at past research for a 
pessimistic portrayal of psychosis illness course (as discussed in the introduction) it is 
important to represent diversity in FEP recovery outcomes; c) psychological models 
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of psychosis aim to understand symptoms that are evident across the psychosis 
spectrum, and therefore it is becoming more common for researchers to examine 
features of psychosis in heterogeneous samples (Kempf, Hussain, & Potash 2005; 
Lake, 2012; van Os, et al, 2009).   
Another limitation of the study sample concerns representativeness.  The 
attrition rate in this study was approximately 20% by Time 2, which is commensurate 
with attrition rates in other FEP studies with similar follow-up duration (Menezes, et 
al, 2006).  Analysis of Time 0 characteristics suggests that, with one exception, those 
lost at follow-up did not differ from those retained in the follow-up sample.  The 
exception to this finding was that those participants missing at follow-up did have 
significantly more severe psychopathology at Time 0 on the GAF symptom measure.  
It seems unlikely that this difference had an impact upon the final results of the study, 
as the GAF Time 0 symptom measure was not a confounding variable in final 
predictor models.  However, it does suggest sample bias: intuitively, one could expect 
that the omission of recovery data of those participants’ with more severe symptoms 
at study entry may have artificially inflated symptom recovery scores in this cohort.  
Conversely, epidemiological research suggests that acuteness of psychosis at onset 
actually predicts better recovery outcomes (Jablensky, et al,1992) and that most 
unrepresentative studies are biased toward retaining information on the most unwell 
patients (Menezes et al, 2006).  While the real impact of these missing data can only 
be speculated, cohort research does unfortunately tend to neglect the outcomes at both 
extreme ends of the recovery spectrum (the very well and very unwell) (Riechler-
Rossler & Rossler, 1998).   
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Approximately 44% of the eligible patients approached to take part in this 
study refused participation and it is important to acknowledge that there may be a 
systematic difference between those patients who consented to take part, and those 
who did not, which may impact upon the generalisability of these findings to the FEP 
population.  Intuitively, one may expect those who did not complete the BCIS 
measure to be less cognitively able that those who did, which may have artificially 
inflated Time 0 BCIS scores.  Notwithstanding these limitations, the access to patients 
and resources available through the GAP project enabled a much larger and well 
characterised sample than could have been achieved, if this study had been conducted 
in isolation.  Further, qualitative analysis carried out to explore reasons for 
participation vs. refusal did not identify any systematic selection bias in participant 
recruitment, and the reasons endorsed for participant refusal were highly (Woodall, et 
al, 2011).     
Follow-up procedures 
Follow-up assessment occurred when participants were willing to be 
interviewed, or when clinical records were available, and so did not always occur 
strictly within the 12 month and five year window.  In fact, only a small minority of 
participants were seen exactly within one month of these follow-up times windows 
(Time 1= 30% Time 2 = 3.4%).  This was a pragmatic approach to data collection 
aimed at minimising the attrition rate; however it may have subsequently limited the 
ability to draw conclusions about discrete stages of psychosis recovery.  This is 
particularly relevant to hypothesis 3, whereby the magnitude of difference between 
BCIS and outcome correlations may have been weakened by a lack of distinct time 
difference between recovery ratings.  Varying follow-up times may also have 
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impacted upon the utility of the hospital admissions measure used in this study, which 
was based on an average, rather than actual number of hospitalisation days (to account 
for different follow-up times).  If it had been possible to collect hospital admission 
days for a set time-frame across the cohort, this variable may have been more 
valuable, as it is likely to reflect the overall recovery trajectory of individual 
participants.  The GAF follow-up rating on the other hand, can only provide a 
‘snapshot’ of recovery status. 
Another limitation of follow-up procedures was the impact of multiple 
researchers upon the consistent and reliable collection of data.  In fact, only one 
researcher (the author) was involved in all three time-points in this study.  This 
involvement of multiple researchers across the study is likely to have reduced a sense 
of continuity for participants (i.e. the researcher calling a participant to arrange 
follow-up appointments was unlikely to be the same person who interviewed the 
participant at previous time-points) and potentially could have made participants  
reluctant to engage in follow-up interviews.  Further, the use of different approaches 
to collect follow-up information (interview and clinical records) no doubt introduced 
some error into this study, but was necessary in order to retain a large data-set (only 
approximately 50% of participants were available for interview at Time 2).  Given the 
context within which this study was undertaken (larger GAP project), it was not 
feasible for all data to be collected by the same researchers across time, and the 
procedures used for data collection reflect the flexibility required to conduct such 
large scale clinical research.  Results from inter-rater agreement and convergent 
validity of the main follow-up measure (GAF) provide some assurance that the 
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flexible procedures adopted to collect follow-up data has not compromised the 
legitimacy of the findings.   
Providing a neuropsychological context  
Establishing the role of the BCIS in a broader neuropsychological model is 
key to understanding the underlying mechanisms of this measure.  This study was 
limited in the sense that only one index of lower-order neuropsychological function 
was measured (IQ) and other specific neuropsychological variables which may be 
better markers of a core cognitive disturbance in psychosis were not measured.  The 
decision not to examine specific lower-order constructs separately in this study was 
informed by the following considerations: a) this study was more interested in 
comparing the contribution of higher-order cognitive factors, and so a lower-order 
cognitive variable was entered as a confounder rather than key variable; b) IQ is an 
important confounder to account for because it encapsulates many different cognitive 
functions; c) there is good evidence that lower-order cognitive deficits have become 
global (i.e. impacting upon IQ) by FEP, though the severity of global deficits may 
vary (Addington, et al., 2005; Joyce et al., 2005; Rund, 1998; Russell, et al.,1997).  
Given the rationale for measuring IQ, the author also concedes that one cannot ignore 
the contentious debate that continues about whether lower-order deficits in psychosis 
are generalised or specific (Cuesta, et al., 2015; Galderisi, et al., 2009; Riley, et al., 
2000). It may have been valuable to measure specific neuropsychological domains, 
such as executive function and memory, both of which have been forwarded as 
candidate markers of cognitive disturbance in psychosis (Bilder, et al., 2000; Joyce, et 
al., 2005; Weikert, et al., 2000).  It is unfortunate that the IQ estimate measure used in 
this study did not index verbal comprehension, or that a verbal memory task was not 
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assessed. This would have been particularly relevant given that verbal memory 
function has previously been shown to be more impaired than IQ, in this Time 0 
sample (O’Connor, et al, 2012), a finding replicated recently in a different large FEP 
sample (n= 451) (Cuesta et al,.  2015). Verbal memories about self may be an 
important precursor to answering items on the BCIS measure in a meaningful way.  
Indeed two FEP studies found significant associations between higher Cognitive 
Insight and better verbal learning and memory (Buchy, Czechowska, et al., 2009; 
Lepage, et al., 2008).   However, it is important to counter this limitation by 
highlighting that such an investigation may not have directly changed the relationship 
between the BCIS scales and recovery in this study.  Indeed, within the previous 12-
month follow-up publication for this sample, neuro-psychological measures of verbal 
memory, or executive functions did not predict recovery outcomes (O’Connor, et al., 
2013). 
Accounting for other predictor variables  
This study accounted for non-cognitive predictor variables that were known 
from the literature to have an impact upon recovery from psychosis (symptoms at 
illness onset, diagnoses and demographic factors) but lacked sufficient statistical 
power to account for other possible predictors of recovery.  Given that regression 
models in this study accounted for between 21.5 to 40% of variance in recovery, a 
larger sample size would have enabled more complex and informative predictor 
models to be constructed.  Particular factors that may have been important to account 
for are; duration of untreated illness (DUP), and ‘help-seeking’ or social disadvantage, 
as these pre-morbid factors may have important interactions with predictor variables, 
particularly those relationships between demographics and function.  Accounting for 
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post FEP treatments could also have been valuable, given that compliance with 
medication and engagement with psychological treatments is likely to have a positive 
impact upon recovery.  Also, it is possible that these variables mediate the relationship 
between self-reflective abilities and better symptom recovery.    
Definitions of Recovery 
Definitions of recovery used in this study took account of different recovery domains, 
however these measures (GAF) were global and somewhat rudimentary.  An 
alternative approach to measuring recovery in this study, would have been to focus on 
specific symptom recovery (i.e. experience of particular symptoms such as persistence 
of delusions or hallucinations over time). In terms of functional recovery, this variable 
could have been defined in more tangible terms, for instance, by using an index of 
social inclusion (i.e. relationship status, employment status or participation in 
community activity). It may also have been valuable to assess recovery in terms of 
engagement with treatment, by measuring compliance with medication or attendance 
to arranged meetings with mental health professionals.  It would have been 
worthwhile to have measured more person-centred aspects of recovery such as 
achievement of personal goals, or subjective quality of life, given that these outcomes 
are increasingly valued in mental health services (Lieberman, et al., 2008; Liberman 
& Kopelowicz, 2005; Slade & Hayward, 2007).  Indeed, what is defined in this study 
as positive recovery (i.e. fewer positive symptoms, greater independence), may not 
agree with all service-users desires for their future. Rather, accounting for subjectivity 
in recovery definitions in outcome-focused research is important (British 
psychological society, 2008).  One example of the type of outcome measure that 
would have added value to this study is CHOICE (choice of outcome in CBT for 
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psychoses) (Greenwood, et al., 2010), which is the first psychometrically sound 
recovery outcome measure designed to account for service-user derived recovery 
priorities such as ‘feeling in control’, ‘having a better understanding of oneself” or 
‘finding a better way of relating to others’.  Although this measure is designed 
specifically for clinical intervention studies (CBTp), adopting similar service-user led 
outcome measures would have made findings in this study more broadly applicable.  
Cognitive Insight may have related differently to these types of recovery outcomes, 
and it would be interesting to evaluate how these personal aspects of recovery 
compare with researcher-led perspectives on recovery. 
Measurement Issues  
A modified BCIS scale was used in this study. A seven-point Likert scale, 
rather than the usual four-point scale, was applied to the questionnaire statements. 
This amended scale had been used in previous research (O’Connor, et al., 2013).  This 
modification was made in order to improve the consistency of the scales which in the 
original publication were below a generally accepted alpha threshold for research of 
.7 (Beck, et al, 2004; Nunnally, 1978).  The benefit of such a modification is 
evidenced by research which shows that inter-item reliability is maximised with a 
seven-point scale (Alliger & Williams, 1992; Finn, 1972; Preston & Coleman, 2000; 
Ramsay, 1973).  Toward this aim, this modification was a success and the internal 
consistency of scale items in this study reached an acceptable level (self-
reflection=.71, self-certainty=.75) and item correlations with respective subscale 
totals were significant, with effect sizes within the moderate to high range (.35 to .72) 
(Cohen, 1992).  However, an acknowledged pitfall of this modification is that item 
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ratings have a greater range in this study than studies that have used the original BCIS 
scale, which makes comparisons to other studies more challenging. 
 Psychometric analyses undertaken by the author suggests that the internal 
consistency of the BCIS scales fall just above commonly accepted statistical 
thresholds (Nunnally, 1978). This has implications for the precision of findings; 
namely low reliability increases the risk of type II errors in this study (i.e. risk of 
failing to identify true associations between the BCIS measured constructs with other 
variables of interest).  Therefore, the current findings should be interpreted cautiously 
and require replication in future studies, perhaps using different, converging  
measures of Cognitive Insight, to support the inferences made about current findings.  
 
Clinical Implications 
The following section will outline how this main finding of this study could 
helpfully inform clinical practice.  Given the positive findings of hypotheses 1, the 
role of self-reflection as a clinically valuable construct is examined.  Findings in 
relation to hypotheses 2 are drawn upon to consider how mental health services could 
better manage functional recovery needs in psychosis.   
Measuring self-reflective capacity to tailor psychological treatment 
A measure of self-reported reflection may provide a useful treatment screen to 
identify the extent to which an individual is likely to engage with psychological 
interventions.  Cognitive therapy, on which CBTp is modelled, challenges an 
individual to distance themselves from symptom experience.  Therefore, it certainly 
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makes sense that an ability to consider one’s own fallibility and the ability to generate 
alternatives (items endorsed on the self-reflective scale) may improve the likelihood 
of being receptive to key CBT techniques.  Also, the ability to reflect on one’s own 
experience has been shown to predict a good therapeutic alliance (Davis, Eicher & 
Lysaker, 2011).  There is a clear clinical priority in identifying individuals that would 
benefit specifically from CBT interventions as it is still difficult to know how to best 
match a person to psychological treatment (Shafran, et al,.  2009). Poor targeting of 
suitable individuals for therapy may be reflected in randomised control trial findings 
that up to 50% of clients partaking in CBTp show limited or no improvement (Garety, 
Fowler & Kuipers, 2000; Kuipers, et al., 1997) and that the pooled effect size of 
overall symptom change for CBTp is modest (Hedges' g= -0.33) when compared to 
alternative talking therapies (Juahar, et al.,2014).   
Clarification of who will benefit from this type of treatment will also help 
refine therapeutic techniques to best cater for individual needs.  For example, while 
self-reflective individuals may be more likely to engage in CBTp, therapeutic 
techniques may need to be tailored to better target the distress that a highly reflective 
client is vulnerable to experiencing.  These individuals may be vulnerable to 
emotional disturbance that arises as a consequence of their psychotic experience.  For 
example, research suggests that increased self-reflection is significantly positively 
correlated with awareness of delusions (Engh, et al.,2010), and this awareness of 
one’s own faulty thinking may have a secondary effect of increasing depressive 
rumination.  There is already an established association between increased clinical 
insight in illness in schizophrenia and depressive symptoms (Mintz, et al., 2003) and 
evidence is emerging that self-reflectiveness as measured on the BCIS scale is also 
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associated with increased depression in psychosis (Belvederi-Murri, et al, 2015; 
Colis, Steer & Beck 2006; Ekinci, et al., 2012; Warman, et al., 2007).  Knowledge 
that an individual already possesses meta-cognitive ability at the beginning of therapy, 
may enable clinicians and clients to focus therapy less towards developing an  
understanding of the psychotic experiences and more upon negative self-evaluation or 
mood disturbance (Garety, et al, 2000). 
While those with high self-reflective skills may engage more easily with CBT 
approaches, individuals with poor self-reflective skills have probably the most to gain 
from CBT in terms of learning to distance themselves from their psychotic symptoms.  
Lysaker and colleagues, who have extensively explored meta-cognition in 
schizophrenia, argue that preliminary input may be required to enable these 
individuals to access this type of therapy, for instance, encouraging clients to notice 
mental processes before guiding them to label and interrogate their thoughts.  They 
suggest this may be achieved by encouraging such clients to verbalise past memories 
and integrate this into a meaningful narrative, as well as practice self -awareness 
strategies explicitly in sessions (Lysaker & Dimaggio, 2014).  Indeed an extended 
duration of engagement is recommended in CBTp (compared to CBT for emotional 
disorders) which enables a flexible approach to accommodate the varied 
psychological needs of clients with psychoses (Jolley, et al., 2015).   
Although CBTp is the best evidenced individualised psychological approach 
for psychosis (NICE guidelines, 2014) other person-based therapies may be better 
suited to individuals with psychosis who have particularly limited self-reflective 
capacity (Lysaker & Dimaggio, 2014).  One such example is Mindfulness-based 
Therapy (Kabat-Zinn, 1994) given its focus on guiding individuals to become better at 
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observing their own sensations, and reactions to them. Mindfulness practice aims to 
draw out meta-cognitive insights into the nature psychosis experiences; enabling an 
individual to create distance between their sense of ‘self’ and their observed 
symptoms.  It is this process of distance that is thought to alleviate psychoses-related 
distress in mindfulness practice (Ellett, 2013) and it is becoming increasingly 
evidenced that this approach is safe and beneficial for psychosis populations 
(Chadwick, 2014). In this way, Mindfulness practice appears to have the same 
therapeutic aim as CBTp (create subjective distance from symptoms), however, it may 
be viewed as a more experiential, and indirect way of achieve this aim (which may 
better suit certain individuals). Mindfulness therapy is often conducted in groups 
(Chadwick, Taylor & Abba, 2005; Jacobson, Morris & Johns, 2011) and group 
contexts may also be conducive to meta-cognitive insights by virtue of providing 
opportunity for individuals to reflect upon other people’s experiences and compare 
that to their own experience.  The research base for mindfulness is limited, although 
some early evidence suggests that this therapy is effective at reducing symptoms and 
improving life function (Chadwick, et al., 2005).  However, at this stage it is unclear 
whether mindfulness is effective because it improves self-reflective capacity, or if it is 
effective for other therapeutic reasons (Chadwick, 2014).   
 
Self-reflection as treatment target in CBTp 
It is unclear whether CBTp is effective because it changes the underlying 
mental structures thought to maintain psychotic symptoms (Garety, et al, 2014) and a 
challenge for researchers is to identify psychological factors that can be modified 
through the course of treatment.  It is possible that self-reflection is a modifiable 
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mental structure and that the BCIS self-reflection scale may be a tangible measure of 
psychosis treatment efficacy.  However as this study was not an intervention design, 
this can only be raised as a matter of speculation.  Evidence about the BCIS suggests 
that the ability to self-reflect may be learnt with therapeutic support, and this might be 
reflected by change scores on the BCIS measure.  For example, psycho-social 
interventions have been shown to change participant endorsement of the self-
reflective scale items, but not endorsement of the self-certainty items (Bora, et al, 
2007; Granholm, et al, 2005).  Further, meta-analysis has shown that the self-
reflective scale has fewer neuro-correlates than the self-certainty scale (Nair, et al, 
2013) which is consistent with findings in this study, that IQ is associated with self-
certainty, and not related to self-reflectiveness.  By virtue of its lack of correlation 
with neuropsychological function in this study, poor self-reflective capacity may well 
be reversed or remedied through psychological input.  Taken together, these findings 
indicate the value of targeting self-reflection capacity to promote symptom change.  
Measuring self-reflection alongside symptom fluctuation over time would be one way 
of shedding light on this process of change.   
The findings from this study only provide evidence for rudimentary 
associations between self-reflection and symptoms, because the symptom measure 
used for recovery indicated global psychopathology (GAF).  The decision to use a 
global measure of symptom outcome, was based on evidence from prior research, 
which suggests that Cognitive Insight (which calculates the cumulative impact of 
different aspects of thinking) is a good predictor of ‘overall’ symptomatology, rather 
than a predictor of specific symptoms (Burton, et al., 2011; Riggs, et al., 2012; 
Perivoliotis, et al., 2010)  . However, given that a relationship to overall symptoms 
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was only found between one aspect of Cognitive Insight  (self-reflection items on the 
BCIS) it would be a fruitful to examine whether this specific aspect of thinking can 
predict the severity of some specific psychotic symptoms more than others (i.e. 
hallucinations vs. delusions).  The literature would benefit from a more fine-grained 
approach to examining the relationship between the BCIS self-reflection scale and 
symptom outcome, with a focus on understanding mechanisms of change between 
these variables. This may be achieved by using an instrument which assesses the 
multi-dimensional aspect of symptoms, such as the psychotic symptom rating scale 
(PSYRATS: Haddock, McCarron, Tarrier & Faragher, 1999) or the Peters Delusional 
Scale (Peters, Joseph & Garety, 1999). These tools differ from the GAF measure used 
in this study, in that they provide an index of specific psychosis symptoms but also 
measure an individual’s relationship to symptom experience, such as individual level 
of distress, conviction and pre-occupation with the experienced symptom. 
Understanding the relationship between the BCIS scales and these specific aspects of 
symptom experience would be particularly informative, and is supported by recent 
calls for the development of symptom-specific interventions in psychosis (Freeman & 
Garety, 2014). What is also not clear from these findings is whether self-reflection can 
predict the severity of some specific psychotic symptoms more than others (i.e. 
hallucinations vs. delusions).  Indeed one previous CBTp intervention found that 
gains in BCIS self-reflection was associated with clinically significant delusional 
improvements, and was not linked to changes in hallucinations (Perivoliotis, et al., 
2010).There is scope for the development of delusion focused treatments, in light of 
recent meta-analysis which suggests that CBTp in its current form, is less effective at 
treating delusions, than it is at treating hallucinations (van der Gaag, Valmaggia & 
Smit, 2014).  
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Service delivery to target functional impairment  
 This section so far has focused on the positive association between self-
reflection and later symptom severity, and how this finding is relevant to clinical 
practice.  However, the study of functional recovery in this thesis revealed findings 
that raise important questions about the mental health service remit.  Functional 
impairment in this study was shown to endure over time, and many risk factors for 
poor functional recovery were identified (functional impairment was almost twice as 
predictable in this study as was symptom severity).  Furthermore, while symptoms 
improved in this cohort, function impairment did not reduce significantly over time.  
Given that this recovery domain showed poorer naturalistic recovery, and was more 
predictable than symptom severity, these findings beg a service delivery question: 
should mental health services prioritise the targeting of functional impairment rather 
than symptom improvement? Such thinking has already influenced mental health 
service provision to some extent, with the creation of community recovery teams, 
designed to reduce symptom experience and promote functional enrichment (British 
Psychological Society, 2008; Repper & Perkins 2003).  While it is assuring that 
findings in this study support the ongoing need for disability-oriented practice, 
findings in relation to risk factors for poor functional recovery need further 
consideration   
  Significant risk factors for poor functional recovery at five years after 
psychosis onset in this study included non-white ethnicity and male gender.  These 
risk factors are enduring, as they were also evident at an earlier follow-up with this 
sample (O’Connor, et al., 2013).  This finding suggests that even with an increased 
focus upon functional impairment within mental health services (Department of 
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health, 2011) men of black and minority ethnic (BME) status are struggling more with 
socio-vocational aspects of recovery following psychosis, than their white, female 
counterparts.  Differences in mental health care access and pathway to care is evident 
across demographic groups, and may help explain this functional inequality.  For 
instance, black, male mental health patients in the UK are less likely to receive a 
referral from GP services (Morgan, et al., 2005a) and their pathway into mental health 
services in the UK is more likely to be through compulsory admission, or the criminal 
justice system (Morgan, et al., 2005b).  Further, their social needs are less likely to be 
taken into account in care-planning (Bhui, et al., 2002).   
Service providers need to ensure that social and cultural groups that are 
identified as being excluded from mainstream mental health pathways are given 
alternative, positive experiences of mental health services.  This service gap is 
currently being met by registered charities such as MAC-UK which is a community 
psychology enterprise that offers mental health support to young, socially excluded 
individuals at risk of violence and offending.  In place of standardised talking 
therapies or medication, MAC mental health workers engage young people, ‘on their 
turf’, collaborating on community projects of the service user’s choosing.  The impact 
of MAC-UK upon functional outcomes is evident: 75% of young people that MAC-
UK engages, go on to training, work experience or education (Youth Justice Working 
Group, 2012).   The success of such initiatives highlights how innovative ways of 
engaging vulnerable client groups can be effective.  Such innovative thinking is 
needed to shape service developments in psychosis health care to reduce exclusion 
and improve functional recovery outcomes in male BME populations.  Such 
interventions could take multiple forms: forging relationships with BME community 
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leaders to advocate mental health issues; better education of mental health staff 
regarding the role that culturally-informed shame may play in help-seeking behaviour; 
and raising health professional’s awareness that distress associated with psychosis 
may manifest differently across gender, social and cultural groups (Rathod, Kingdon, 
Phriri & Gobbi, 2010).  It is also important that current evidenced-based approaches, 
such as CBTp, are culturally adapted according to published recommendations, to 
ensure that social/cultural beliefs are incorporated into treatment (Habib, Dawood, 
Kingdon & Naeem, 2015; Rathod, et al., 2010). 
Future Research   
This future research section is limited to exploring ideas for future research 
focused on the main positive finding in this study; that self-reflection is a predictor of 
later symptom recovery in FEP.  It is suggested that a thorough examination of the 
BCIS self-reflection measure in different contexts is warranted and would improve 
the current literature base.  Avenues for empirical exploration are described below.  
Investigating self-reflection and CBTp relevant variables  
It is speculated in the clinical implications section of this chapter that 
individuals with better self-reflective capabilities may be more likely to engage in 
CBTp.  Despite NICE recommendations, only 10% of current UK mental health 
services deliver CBTp routinely (Jolley, et al., 2015; the Schizophrenia Commission, 
2012) and therefore research that identifies psychological predictors of engagement 
with therapies may improve service delivery.  Such research may also clarify the 
mechanisms through which self-reflectiveness is associated with better symptom 
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recovery, as was found in this study.  For instance, it would be useful to know whether 
increased engagement in CBTp is a mediator between self-reflectiveness and 
symptom outcome, or whether the relationship is direct.  Another plausible hypothesis 
is that high pre-therapy BCIS self-reflection predicts better response to ‘hypothetical 
contradiction’ (a CBTp therapist technique) and belief flexibility, which in turn leads 
to better response to treatment.   
Tracking self-reflection change over time 
The BCIS measures were only administered at one time point in this study, 
which is unfortunate given that hypothesis 3 suggests a complex longitudinal 
relationship between the BCIS subscales and phase of illness.  The literature would 
certainly benefit from research investigating the stability of both BCIS subscales over 
multiple time-points, and to closely monitor how sensitive recovery outcomes are to 
changes in BCIS scores.  For instance, the notion that self-reflective capacity may 
have a fine-grained relationship with delusions (discussed in clinical implications) 
could be closely monitored, using Experience Sampling Methodology (ESM: Myin-
Germeys, Nicolson & Delespaul 2001).  ESM is a random time-sampling technique 
that enables moment to moment thoughts and experiences to be traced over a short 
period of time, as well as measuring the role of contextual factors (activity, persons 
present, mood) upon changes to thinking.  Researchers could request FEP participants 
to complete the BCIS self-reflection scale at random times of the day (indicated by 
ESM random beeper) and also record delusional aspects of thinking across the same 
time period.  This would enable variability of self-reflective scores across time (and 
contexts) to be monitored, which will inform understanding of its state or trait-like 
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character.  It will also allow temporal changes in the BCIS to be compared with 
delusional fluctuations, to identify the precise nature of this relationship.   
Manipulating self-reflection in an intervention study 
If it is the case that self-reflection changes over time, then research needs to go 
beyond the detection of associations and use designs that can manipulate this 
construct.  The role of self-reflection, as measured on the BCIS in CBTp and other 
therapies, has been inferred. It has not been directly targeted, however.  A treatment 
program could be implemented, with the objective of increasing introspection and 
subjective fallibility directly and measuring whether self-reflective capacity can 
indeed be changed through targeted intervention.  A therapy program could be 
developed either in a single case experimental design, or by comparing this type of 
intervention to other therapies that have a different focus of change.  Evaluating the 
BCIS self-reflection scale on a regular basis during therapy and observing concurrent 
symptom change would be an effective way of measuring whether such an 
intervention was effective. 
 Validation of the BCIS self-reflection scale   
The fact that the BCIS is the only instrument that purports to measure 
Cognitive Insight has both advantages and disadvantages.  On one hand, this allows 
comparisons across studies and reduces error that is sometimes introduced by 
measuring a construct in multiple ways (Mintz, et al., 2003), however, it limits 
opportunity to evaluate whether the BCIS actually measures what it purports to 
measure.  While the self-certainty scale did correlate with an objective measure of 
reasoning bias (JTC on the Beads Task), no such convergent validity was assessed for 
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the self-reflective scale.  At present, there is no way of verifying whether item 
responses on the BCIS self-reflective scale converge with the behavioural application 
of meta-cognition in daily life (i.e. the act of endorsing self-reflection via a 
questionnaire may not require self-reflection in the moment).  Therefore, it may be 
helpful for future research to examine level of agreement between the BCIS and other 
third party tools of self-reflection, such as the newly developed meta-cognition 
assessment scale, which measures self-reflective behaviour through examining an 
individual’s narrative discourse (Lysaker, et al., in press).     
Conclusion  
Through employing a longitudinal design, evidence has emerged in this study 
which supports a causal role for meta-cognition in the maintenance of 
psychopathology in early psychosis.  That is, the ability to self-reflect precedes the 
experience of symptoms in this sample.  The comparison of higher-order cognitive 
factors (self-reflection and confidence in judgement) in relation to broad recovery 
outcomes in psychosis is novel, as is the examination of changes to these relationships 
across different phases of illness course.  This research is partially in support of 
cognitive models of psychosis, and suggests that meta-cognition may be better at 
predicting future recovery in the FEP than reasoning style.  Not only did symptom 
outcomes significantly improve over a five year period, but it was also refreshing to 
find that a possibly malleable psychological factor has an impact on symptom 
recovery.  These findings provide an optimistic outlook for recovery, and reveal a 
potentially important target for psychological intervention.  It is hoped that the 
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findings of this study contribute to an invigorated research interest in self-reflective 
aspects of cognition in early psychosis. 
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Appendix C 
Global Assessment of Functioning (GAF) Scale – SYMPTOMS 
 
Consider psychological functioning on a hypothetical continuum of mental health-
illness. Rate symptoms over the last week before interview. 
100-91 No symptoms. 
90-81 Absent or minimal symptoms (e.g. mild anxiety before an exam). 
80-71 
If symptoms are present they are transient and expectable reactions to 
psychosocial stresses (e.g. difficulty concentrating after family argument). 
70-61 Some mild symptoms (e.g. depressed mood and mild insomnia). 
60-51 
Moderate symptoms (e.g. flat affect and circumstantial speech, occasional panic 
attacks). 
50-41 
Serious symptoms (e.g. suicide ideation, severe obsessional rituals, frequent 
shoplifting). 
40-31 
Some impairment in reality testing or communication (e.g. speech is at times 
illogical, obscure or irrelevant). 
30-21 
Behaviour is considered influenced by delusions or hallucinations OR serious 
impairment in communications or judgement (e.g. sometimes incoherent, acts 
grossly inappropriately, suicidal preoccupation). 
20-11 
Some danger or hurting self or others (e.g. suicide attempts without clear 
expectation of death, frequently violent, manic excitement) OR gross 
impairment in communication (e.g. largely incoherent or mute). 
10-1 
Persistent danger of severely hurting self or others (e.g. recurrent violence) 
serious suicidal act with clear expectation of death. 
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Global Assessment of Functioning (GAF) Scale - DISABILITY 
 
Consider psychological, social and occupational functioning on a hypothetical 
continuum of mental health-illness. Do not include impairment of function due to 
physical or environmental limitations. Rate functioning over the last week before 
interview. 
100-91 
Superior functioning in a wide range of activities; life’s problems never get 
out of hand; is sought out by others because of his/her positive qualities. 
90-81 
Good functioning in all areas, interested and involved in a wide range or 
activities, socially effective, generally satisfied with life, no more than 
everyday problems or concerns (e.g. an occasional argument with family 
members). 
80-71 
No more than slight impairment in social, occupational, or school functioning 
 
(e.g. temporarily falling behind in school work). 
70-61 
Some difficulty in social, occupational, or school functioning (e.g. occasional 
truancy, or theft within the household), but generally functioning pretty well, 
has some meaningful interpersonal relationships. 
60-51 
Moderate difficulty in social, occupational, or school functioning (e.g. few 
friends, conflicts with co-workers). 
50-41 
Any serious impairment in social, occupational, or school functioning (e.g. no 
friends, unable to keep a job). 
40-31 
Major impairment in several areas, such as work or school, family relations, 
judgement, thinking, or mood (e.g. depressed man avoids friends, neglects 
family, and is unable to work; child frequently beats up younger children, is 
defiant at home, and is failing at school). 
30-21 
Inability to function in almost all areas (e.g. stays in bed all day; no job, home 
or friends). 
20-11 
Occasionally fails to maintain minimal personal hygiene (e.g. smears faeces) 
OR gross impairment in communication (e.g. largely incoherent or mute). 
10-1 Persistent inability to maintain minimum personal hygiene. 
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Appendix D 
PANSS 
Instructions: Tick the term for each symptom which best describes the patient’s condition over the last 7 days and 
not relative to any other time. For more detailed information on each PANSS item, and to make ratings, you should use 
the PANSS Manual of Definitions 
 
 
 
Negative Scale    SCORE    
 
         
 
ITEM Absent Minimal Mild Moderate 
 Moderate 
Severe Extreme   Severe          
 
          
N1: Blunted affect 1 2 3 4  5 6 7 
 
         
 
N2: Emotional withdrawal 1 2 3 4  5 6 7 
 
         
 
N3: Poor rapport 1 2 3 4  5 6 7 
 
         
 
N4: Passive/apathetic social 
1 2 3 4 
 
5 6 7  
withdrawal 
 
 
        
 
          
N5: Difficulty in abstract 
1 2 3 4 
 
5 6 7  
thinking 
 
 
        
 
         
 
N6: Lack of spontaneity and 
1 2 3 4 
 
5 6 7  
Flow of conversation           
 
N7: Stereotyped thinking 1 2 3 4  5 6 7 
 
         
 
Positive Scale    SCORE    
 
         
 
ITEM Absent Minimal Mild Moderate 
 Moderate 
Severe Extreme   Severe          
 
          
P1: Delusions 1 2 3 4  5 6 7 
 
         
 
P2: Conceptual disorganization 1 2 3 4  5 6 7 
 
         
 
P3: Hallucinatory behaviour 1 2 3 4  5 6 7 
 
         
 
P4: Excitement 1 2 3 4  5 6 7 
 
         
 
P5: Grandiosity 1 2 3 4  5 6 7 
 
         
 
P6: Suspiciousness / persecution 1 2 3 4  5 6 7 
 
         
 
P7: Hostility 1 2 3 4  5 6 7 
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General Psychopathology Scale    SCORE    
 
         
 
ITEM Absent Minimal Mild Moderate 
 Moderate 
Severe Extreme   Severe          
 
          
G1: Somatic concern 1 2 3 4  5 6 7 
 
         
 
G2: Anxiety 1 2 3 4  5 6 7 
 
         
 
G3: Guilt Feelings 1 2 3 4  5 6 7 
 
         
 
G4: Tension 1 2 3 4  5 6 7 
 
         
 
G5: Mannerisms and Posturing 1 2 3 4  5 6 7 
 
         
 
G6: Depression 1 2 3 4  5 6 7 
 
         
 
G7: Motor Retardation 1 2 3 4  5 6 7 
 
         
 
G8: Uncooperativeness 1 2 3 4  5 6 7 
 
         
 
G9: Unusual thought content 1 2 3 4  5 6 7 
 
         
 
G10: Disorientation 1 2 3 4  5 6 7 
 
         
 
G11: Poor attention 1 2 3 4  5 6 7 
 
         
 
G12: Lack of judgment and 
1 2 3 4 
 
5 6 7  
insight 
 
 
        
 
          
G13: Disturbance of volition 1 2 3 4  5 6 7 
 
         
 
G14: Poor impulse control 1 2 3 4  5 6 7 
 
         
 
G15: Preoccupation 1 2 3 4  5 6 7 
 
         
 
G16: Active social avoidance 1 2 3 4  5 6 7 
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Appendix E 
Beck Cognitive Insight Scale:  Below is a list of sentences about how people think and feel. Please read 
each sentence in the list carefully. Indicate how much you agree with each statement by placing an X in the 
corresponding space in the column next to each statement. 
 
 
 
 
Do not agree  
at all 
Agree slightly Agree a lot Agree completely 
 1 2 3 4 5 6 7 
At times, I have misunderstood other 
people’s attitudes towards me. 
 
       
My interpretations of my experiences 
are definitely right 
 
       
Other people can understand the cause 
of my unusual experiences better than 
I can. 
 
       
I have jumped to conclusions too fast 
 
       
Some of my experiences that have 
seemed very real may have been due 
to my imagination. 
 
       
Some of the ideas I was certain were 
true turned out to be false. 
 
       
If something feels right, it means that 
it is right. 
 
       
Even though I feel strongly that I am 
right, I could be wrong. 
 
       
I know better than anyone else what 
my problems are 
 
       
When people disagree with me, they 
are generally wrong. 
 
       
I cannot trust other people’s opinion 
about my experiences. 
 
       
If somebody points out that my beliefs 
are wrong, I am willing to consider it 
 
       
I can trust my own judgment at all 
times. 
 
       
There is often more than one possible 
explanation for why people act the 
way they do. 
 
       
My unusual experiences may be due to 
my being extremely upset or stressed. 
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Appendix G 
 
Information and Consent Form (not for data entry) 
 
You have been asked to take part in a study being conducted in the South London and 
Maudsley NHS Trust. Before you decide whether to enter the study, it is important that 
you understand why the research is being done and what it will involve. Please take 
time to read the following information and ask any questions if something is not clear 
or you wish to know more. 
 
TITLE OF PROJECT: GENETICS AND PSYCHIATRIC ILLNESS (GAP) 
 
What are the aims of the study? 
 
In our research project we are interested in identifying what the main risk factors that 
predispose to psychosis are. In particular, we want to know whether there are any genes that 
increase the risk of developing a psychotic disorder, either alone or by interacting with 
environmental factors such as stress, cannabis, and infections. Part of the reason why some 
people become ill may lay in genetic differences between people, in the same way that we 
are different in the colour of our eyes, hair etc. To achieve this, we will compare the genetic 
make-up of people with a diagnosis of psychosis with the make-up of people with similar 
characteristics but no history of mental health problems. 
 
We also aim to establish whether some genes might influence the course of the illness and 
response to medication. Some patients experience an improvement of their psychiatric 
symptoms when they are treated with medications, whereas others do not do so well and/or 
experience severe side-effects. Therefore we aim to look at how genes can influence 
individual differences in response to drug treatment so that we may be able to choose better 
drugs for each person. The type of genetic analysis that we carry out is only for research 
purposes and does not at present produce clinically relevant results. 
 
Finally, an additional aim of the study is to understand how the social environment may 
contribute to the onset of illness and the illness experience. 
 
Why are we asking for your help? 
 
You have been invited to take part in this study because of the nature of the symptoms that 
you appear to have been experiencing. During the course of the study approximately 1000 
people who have had symptoms like yours will be asked to take part. 
 
Note that a patient does not have to be involved in the GAP project research and, if they 
decide not to take part, it will not affect their current or future medical care in any way. 
 
What will we ask of you if you take part in the study? 
 
For this project we will ask from you a small sample of blood, about 20 mL (a few tablespoons 
full) or cheek swab and saliva samples for metabolic and genetic analysis. We may also use 
your blood and saliva sample to: 
 
1) Measure the level of hormones and proteins contained in the blood serum and in the 
saliva.  
2) Look at the expression of some genes of interest in the white cells contained in the 
blood. 
 
A medically trained researcher will take the blood sample using disposable sterile equipment. 
It will only take few minutes as for any routine blood sample. If you are unable or unwilling to 
give a blood sample it is also possible to perform genetic analysis from cheek swab samples, 
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a simple procedure that (we can show you the kit and illustrate the procedure) collects dead 
cells present in your saliva and in your mouth. From the cheek swab sample we cannot 
measure level of medication or look at expression of genes, we can only extract a small 
amount of DNA. Therefore we prefer to ask for a blood sample to guarantee a better quality of 
our results and make the most out of your generous help. A researcher will demonstrate how 
to collect the saliva sample and will provide you with the tubes required. The level of some 
proteins contained in the saliva can give us an indication of differences in the level of stress 
experienced by healthy volunteers and people suffering from mental illnesses. 
 
We will also ask for some of your time to collect clinical and socio-demographic information 
using standardised research instruments: diagnostic interview, symptoms rating scale, socio-
demographic interview and neuropsychological tests. We may also ask you to participate in 
an interview asking about your own perspectives on your social environment and your health 
condition. 
 
If you have already taken part in other research projects at the Institute of Psychiatry, London 
that involved some of the assessment we are interested in, we will not ask you to undergo 
them again but we request your permission to use the existing data. 
 
Some people within the study will be invited to undergo an MRI scan of the head and of 
another region of the body (the adrenal gland, a small gland above the kidney).They will be 
presented with separate information and consent forms for this procedure. 
 
The sample collection and the clinical assessment will require approximately 3 hours of your 
time. Moreover we would like to contact you again for follow up (up to 24 months) to repeat 
the above assessments to investigate changes over time. We will also reimburse any travel 
expense related to your participation into the study. 
 
We will also ask for your consent to contact your GP, mother (or father) and a sibling. This is 
1) to collect information from your GP records and mother about events that may have 
occurred very early in your life, such as complications during pregnancy and neonatal 
infections, 2) to conduct some of the same assessments with your sibling that we have 
conducted with you, and 3) to ask your sibling similar questions that we have asked you 
about the environment in which you both grew up and experiences you may have had in 
childhood. We will only contact your GP and/or relative(s) with your explicit consent and we 
will not disclose any information we have collected from you to them. If you agree for us to 
contact your mother (or father) and/or a sibling, we will only proceed to interview them if they 
provide consent. 
 
What are the risks? 
 
The risks involved are those of ordinary blood tests such as small pain and occasionally a 
small bruise around the area from where the sample has been taken. There is no risk 
involved in the collection of saliva. 
 
Is Confidentiality guaranteed? 
 
All personal information about you is regarded as strictly confidential; only researchers 
belonging to the study team, and not external collaborators, know which sample belongs to 
whom. All the information about you will be coded; you will not be identifiable in any research 
outcome. 
 
1) The blood samples first and the DNA samples after extraction will be stored in the 
Institute of Psychiatry secured laboratory until reporting is complete.  
2) The samples will be coded using bar codes (numbers and letters not referring to your 
name or date of birth) that will be entered on a secure computerized data base.  
3) The clinical information collected on the sample will be securely held in the Institute of 
Psychiatry building.  
4) Nothing that you have told us will be mentioned to any relative you might give us 
permission to contact. 
The access to the samples and the related information will be restricted to the researchers 
involved in the study. In case of commercial collaborations only the coded data will be shared, 
therefore no researcher external to the study team will ever have access to personal data 
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concerning participants. 
 
Any future work will pursue aims related to the topic of this project and any extension of the 
project beyond 5 years, will be subject to review by a research ethics committee. You are free 
to withdraw from this study at any point without giving a reason by contacting the researcher 
whose details are at bottom of the consent form. Withdrawal will not affect any of the care and 
treatment you receive. 
 
What are the benefits for you of taking part? 
 
This is a research project, looking at comparing a group of healthy volunteers with people 
experiencing their first psychotic episode. As mentioned before, this study will not produce 
individual test results for any of the data collected. Therefore we cannot offer direct benefits 
for you. We will be able to provide all participants with a general summary of our research, 
when the project is complete, through a project newsletter. Our research study is also 
described on the Institute of Psychiatry general website (www.iop.kcl.ac.uk), under the 
Department of Psychosis Studies section. 
 
Who is funding this project? 
 
This study is funded by the The Maudsley Charitable Fund, the Department of Health, the 
Wellcome Trust and the European Union. Thank you very much for your time and once 
again please ask for more information on both the project and/or your illness/symptoms if it is 
still unclear. 
 
Contact details for research team: 
 
Dr Marta Di Forti 
Institute of Psychiatry  
Tel 020 7848 5352 e-
mail: marta.diforti@kcl.ac.uk 
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CONSENT FORM 
 
If you have come to the decision to enter the study after carefully considering the 
information provided, please read and sign this form. 
 
TITLE OF PROJECT: GENETICS AND PSYCHIATRIC ILLNESS (GAP) 
Researcher: Dr Marta Di Forti, Institute of Psychiatry 
 
1)  I have read the information sheet and I have been given a copy. I was given Yes No

 
 
 the opportunity to ask questions. I understand why the research is being   
 
 done and the risks involved.   
 
2) I agree to give a sample of blood/cheek swab and saliva samples for Yes No 
 
 research in the above project. I understand how the sample will be collected,      
 
 that giving the sample is voluntary and that I am free to withdraw at any time   
 
 without giving a reason, and without my medical treatment or legal rights   
 
 being affected. I understand that I will be contacted in the future to repeat part   
 
 of the assessment.   
 
3)  I understand that research using the sample I give will involve genetic Yes No 
 
 analysis aimed at understanding the role of genes in disease and response  
 
 to  drugs,  that  the  data  produced  are  for  research  rather  than  clinical   
 
 purposes, and that these results will have no implications for me personally.   
 
4)  I understand I will not receive any 'test' results from this study, because Yes No 
 
 the assessment I will undergo, does not produce clinically relevant information      
 
 but just research  data. The  project  newsletter  will  describe  the  general   
 
 importance of any research results obtained.   
 
5)  I give permission for my previous research records to be looked at, and Yes No 
 
 information  from  them  to  be  analysed  in  strict  confidence  by  
 
 responsible  professional staff  from  the  research  team.  Researchers   
 
 external to the study team, collaborating in the project (including commercial   
 
 collaborations) will only access my coded data.   
 
6)  I agree that the samples I have given and the information gathered about Yes No 
 
 me  can  be  examined  and  stored until  reporting  is complete at  the  
 
 Institute of Psychiatry. I understand that future authorised research may be   
 
 performed by researchers other than those who conducted the first project,   
 
 including   researchers   from   commercial   organisations.   To   guarantee   
 
 confidentiality, I agree that researchers external to the study team, including   
 
 those from commercial collaborators, will only have access to coded data and   
 
 not to personal details. Any future research will only pursue aims related to   
 
 the topic of this project, and any extension of the project will be subjected to   
 
 review by a research ethics committee.   
 
7)  I consent to the input of coded data obtained from my blood sample and Yes No 
 
 from the information gathered about me into a computer, to be used for  
 
 statistical analysis and research. I understand I have the right to request,   
 
 via the study co-ordinator, to review data concerning me, and to have such   
 
 data modified if inaccurate, or deleted.   
 
     
 
8) I consent to participate in a digitally-recorded interview about my own  Yes No 
 
  perspectives  on  my  health  condition  and  on  my  social  experiences.  I         
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understand that this interview would be recorded to ensure that my own views are 
adequately represented. 
 
9)  I understand I will not benefit financially if  this  research leads  to  the               Yes  No 
 
evelopment of a new treatment of medical test but my travel expenses will     
 
be reimbursed.      
  
10) I give permission for my GP records to be looked at. Yes No 
    
11) I agree to my mother being approached to participate in this study. Yes No 
 
 
 
 
Contact details: 
 
Name ……………………………………………………………………………………. 
 
Address ……………………………………………………………………………....... 
 
……………………………………………………………………………………………. 
 
Phone Number ………………………………………………………………………… 
 
 
12) I agree to a sibling being approached to participate in this study. Yes No 
 
 
 
 
Contact details: 
 
Name ……………………………………………………………………………………. 
 
Address ……………………………………………………………………………....... 
 
……………………………………………………………………………………………. 
 
Phone Number ………………………………………………………………………… 
 
 
……………………………………………. ………………….. ………………………… 
Name of Subject Date Signature 
……………………………………………. ………………….. ………………………… 
Name of Researcher Date Signature 
 
 
  
Would you like to be sent further information about the project in our newsletter? Yes  No 
Contact details for research team: 
 
Dr Marta Di Forti 
Institute of Psychiatry 
Tel 020 7848 5352 
e-mail:  
marta.diforti@kcl.ac.uk 
